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ABSTRACT 
Few studies have documented patients’ perspectives on interventions designed to 
change health behaviors.  Understanding constructs of interventions that patients’ identify 
support health behavior choices may help explain variation in interventions effectiveness.  
Therefore, our objective was to understand patients’ perspectives of participating in 
studies that incorporated technology to improve health outcomes and the impact of the 
intervention on health behaviors.   
In-depth interviews were conducted with patients in two studies incorporating 
technology to improve health outcomes.  Transcripts of interviews were analyzed using 
content analysis and grounded theory approaches.  Health behavior surveys were used to 
assess the association between the intervention and health behaviors. 
Establishing bi-directional conversations between patients and providers is a key 
factor to improve cardiac care and to positively influence health behaviors.  Bi-directional 
conversations occur when patients are comfortable to honestly share their intentions to 
adhere to evidence based recommendations.  Furthermore, providers are comfortable to 
hear divergent opinions of the recommendations and work with patients towards an 
agreed upon treatment plan.  Active participation in this decision-making process of 
healthcare removes barriers of communication and empowers patients to share concerns, 
fears, and issues providing clinicians with information about barriers to adherence.  
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Additionally, we found increased interactions with health professionals augmented by 
technology improve knowledge of cardiac issues and health behaviors. 
Our findings complement previous research and contribute a deeper level of 
understanding factors associated with positive health behaviors.  Bi-directional 
communication is necessary for comprehensive decision-making.  Future interventions 
designed to improve medication adherence should incorporate these patient-identified 
factors. 
 
The form and content of this abstract are approved.  I recommend its publication. 
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Cardiovascular disease (CVD) is the single leading cause of death and disability 
in the United States. Prevention and management of CVD is a public health goal that 
remains a major challenge. (1-2)   Treatment of CVD involves medication therapy where 
appropriate and patients’ adherence to lifestyle changes and/or medications.  However, 
adherence rates are about 50% for medications and are much lower for lifestyle 
changes; significantly jeopardizing treatment success. (3-7)  The consequences of poor 
health behaviors are worsening disease status and increased mortality rates for patients 
while increasing health care costs to society. (6)  Therefore, improving CVD outcomes 
remains a challenge and is dependent on understanding and improving patients’ health 
behaviors. 
Recent studies of cardiovascular outcomes explore the effectiveness of 
multifaceted interventions targeting health behaviors and medication adherence with 
varying results. (8-25)  These multifaceted interventions generally incorporate more than 
one component: communication technologies, home monitoring, patient education, and 
frequent interactions with providers through technology.  Because health behaviors are 
multi-factorial in nature, multifaceted interventions are usually more successful than uni-
modal interventions.  Knowledge of the patient choices and understanding the reason 
behind their decisions may explain the varying degrees of effectiveness of these 
interventions. (26)  Patients choose to participate in interventions and choose to execute 
the prescribed behaviors.  Furthermore, they have the option of either not doing what 
has been requested or modifying their behavior in such a way that it changes the 
integrity of the intervention.  Yet, few cardiovascular studies have investigated the 
2 
 
effectiveness of multifaceted interventions on patients’ outcomes and their health 
behavior decisions from the perspective of the individual participant.  
Understanding how the intervention modifies patients’ health behaviors is 
important to the overall success of the intervention.  There are numerous health 
behavior theories that help explain the multitude of factors that influence human 
behavior.  One such model is the Transtheoretical Model of Behavior Change (TTM), (27-
31) which focuses on the decision-making abilities of the individual.  Investigation of 
specific constructs of TTM (self-efficacy and stage of change) may shed light on whether 
or not the intervention influenced changes in the patients’ health behavior.  
Therefore, this thesis gathers an in-depth understanding of the patients’ 
experience of participating in multifaceted cardiac interventions and their perspective of 
how the interventions affect their health behavior decisions and outcomes.  The 
investigation uses qualitative analyses that incorporate an iterative, inductive, and 
deductive toolkit of analytical strategies.  In addition, this thesis assesses the association 
of an intervention on cardiovascular outcomes mediated by specific health behavior 
components (self-efficacy and stage of change) using both univariate and multivariate 
quantitative analyses.  
 
Theoretical and Empirical Frameworks 
Theoretical and empirical frameworks provide researchers with concepts, 
principles, and rules for shaping and conducting research. (32-33)  This thesis utilizes 
multiple frameworks to support the various components of the research.  A pragmatic 
paradigm is used to provide a conceptual framework for this research and supports the 
use of a mixed methodology. (32-33)   To further ground the methodological development 
of this thesis, additional substantive theoretical and empirical frameworks support the 
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use of obtaining patients’ perspectives of their experience with the interventions.  
Theories of Ray Pawson (31) and the Medical Research Council (37-38) explore the 
importance of subjective views of an intervention and understanding why they are useful 
and needed.  Finally, the Transtheoretical Model of Behavior Change is used to explain 
the factors that influence human behavior.  In the following discussion, we delve into 
each framework and describe how it supports this thesis. 
A pragmatic paradigm focuses on the outcomes of research, such as the actions, 
situations, and consequences of inquiry, rather than precursor conditions. (32-36) Patton 
defines pragmatism as using what works to find solutions to problems. (33)  Pragmatism 
examines practical consequences and empirical findings in order to decide which action 
to take as one attempts to better understand real world phenomena. (35)  Therefore, a 
pragmatist is not committed to one philosophy, such as positivism that quantitative 
researchers may ascribe to or constructivism that a qualitative analyst may believe. 
Pragmatists are open to many approaches to collecting and analyzing data. (32-33)  The 
goal is to draw from the strengths of each philosophy and methodology within the 
philosophical paradigm and to minimize the weaknesses of both. (35)  Consequently, a 
pragmatic paradigm is ideal for inquiry into health services research where the intent is 
to evaluate quality of care, develop clinical practice guidelines, and foster effective 
interventions to improve quality of care. (35)   
Health services outcomes research examines the effects of interventions and 
policies on the health outcomes of individuals and society. (34)  Examination of health 
care utilization, cost, and clinical effectiveness lend themselves to quantitative inquiry. 
However, other complex aspects such as organizational change, implementation of 
evidence-based guidelines, and patients’ perceptions of their clinical care are well suited 
for qualitative inquiry. (34)  Therefore, a pragmatic paradigm is valuable for this research 
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because we can capitalize on the use of a mixed methodology and utilize the strengths 
of both qualitative and quantitative inquiry.   
To further ground the methodological development of this thesis we use the 
theories of Pawson (31) and the Medical Research Council. (37-38) Theories of Ray Pawson 
(31) and the Medical Research Council (37-38) explore the importance of subjective views of 
an intervention and understanding why they are useful and needed are presented. 
The theoretical framework of Ray Pawson (31) supports exploring individual 
perspectives of the intervention participants.  Pawson notes that interventions are based 
on hypotheses and multifaceted interventions, by definition, have more than one theory. 
(25, 31) The success of an intervention depends on the cumulative success of the entire 
sequence of theories as well as the efficacy of each step in a long implementation chain.  
Interventions are open systems, active, and permeable, and therefore have intended 
and unintended outcomes. (31)  Multifaceted interventions offer resources and advice, 
which may be welcome, heeded, and acted upon.  Equally, they may be missed, 
ignored, forgotten, and thus overlooked; or just not done. (31)  Interventions work through 
the patients’ reasoning, which are the triggers of change intended by the intervention.  
Knowledge of that reasoning is integral to understanding interventions outcomes. (31)  
Patients choose to make the interventions work and have the ability to respond in ways 
that were not expected, thus shaping and reshaping the intervention. (31)  What this 
means is that patients’ select medical advice or aspects of interventions they believe to 
be beneficial or are conducive to their lifestyle, which affects the outcome of the 
intervention.  Thus, when assessing the effectiveness of the interventions, it is very 
important to understand the patients’ perspective of the interventions.   
Therefore, due to the complexity of multifaceted interventions, evaluations 
assessing the effectiveness are difficult and must take into account the various 
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components of the intervention that may act independently and interdependently.  In 
addition, evaluations need to consider patient and organizational factors and the number 
and difficulty of behaviors required by those receiving the intervention. (37-38)  The 
empirical framework of the Medical Research Council (MRC) (37-38)  for designing and 
evaluating multifaceted interventions paradigm includes the importance of going beyond 
evaluating overall effectiveness to studying the component processes and how they vary 
among patients. (37-38) The Conceptual Model of this thesis stems from the Medical 
Research Council framework, which defines multifaceted interventions as having 
interacting components.  In order to properly evaluate the multifaceted interventions it is 
important to not only understand which components the patients believe to be effective 
but also take into account the effectiveness of the combined intervention.  The 
evaluation must also consider how the intervention affected the patients’ health behavior 
to fulfill the prescribed lifestyle changes and improve adherence.  In addition, it is 
important to understand how the effects vary between patients and sites.  Finally, the 
evaluation results may be used to improve the overall effectiveness of the intervention. 
(37-38) 
To fully understand the patients’ perspectives of their experience of the 
intervention and the effect the intervention may have had on the patients’ health 
behaviors we must be aware of the factors that influence health behaviors.  Therefore, 
this thesis uses the Transtheoretical Model (TTM) to help explain and explore the factors 
that influence patients’ behaviors.  TTM focuses on the decision making abilities of the 
individual and includes four main constructs: the stages of change, processes of change, 
self-efficacy, and decisional balance. (27-31)  Attempting to understand a concept as 
complex as health behavior necessitates using a model that works towards classifying 
and explaining the multitude of factors that can and do influence human behavior. (39-40)  
6 
 
The TTM indicates that health behavior change is a process where patients are at 
various level of motivation to change.  The process is described as cyclical where people 
enter and exit at any point and often recycle.  The specific points are described as 
“stages” and there are five distinct stages.  Therefore, interventions may affect change in 
their stage, thus improving their motivation to change and support their effort to improve 
their health behavior with skills and information. (39-40)  For that reason, this thesis 
assesses the change in behavioral constructs after participation in the study.  A 
comparison between the intervention and the usual care groups is also assessed. The 
final assessment investigates if health behaviors mediate the association of the 
intervention with adherence outcomes.  
Theoretical and empirical frameworks provide researchers with concepts, 
principles, and rules for shaping and conducting research.  To ensure valid creation and 
integration of evidence to produce a high quality research project, this thesis is being 
guided by multiple frameworks to ensure valid creation and integration of evidence to 
produce a high quality research project. 
 
Purpose 
The primary purpose of this thesis is to gather an in-depth understanding of the 
patients’ experience of participating in multifaceted cardiac interventions and their 
perspectives of how the interventions affect their health behavior decisions and 
outcomes. 
The secondary purpose is to assess the association of an intervention on 
cardiovascular outcomes mediated by specific health behavior components (self-efficacy 






The Medical Research Council defines complex interventions to be those “built 
up from a number of components, which may act both independently and 
interdependently”. (38)  Thus the evaluation is challenging because interpreting the results 
can be difficult.  Are the results due to an effective/ineffective study design or due to the 
effective/ineffective implementation of the study design by the facility?  Finally, is it clear 
whether or not the patients’ participation is in accordance with the prescribed process of 
the intervention? To answer these questions, the MRC proposes a framework to define 
the problem: design and evaluate the intervention simultaneously.  This iterative process 
separates the individual components allowing for a better understanding of each part 
and how it affects the other component through simultaneous evaluations.  A greater 
understanding of the individual components facilitates a more effective intervention. 
Although we cannot retrospectively follow the MRC framework, we can 
prospectively apply the concept of evaluation of the participants’ perspectives of the 
intervention and apply the lessons learned back into the study design. The knowledge 
gained from the patients will improve the intervention constructs and facilitate the 
translational process into clinical cardiac care.  
Therefore, our Conceptual Model stems from the Medical Research Council’s 
framework that an optimized intervention has multiple components intended to improve 
clinical outcomes (Figure 1).  These interventions need appropriate evaluations that 
assess the various components as well as the overall effectiveness.  
Evaluation of multifaceted interventions therefore, includes both understanding 








































Figure 1. Modified Medical Research Council’s Evalu ation for Complex 
Interventions Conceptual Model 
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perceptions of the effectiveness of the combined intervention.  The optimized evaluation 
also takes into account how the intervention affected outcomes such as patients’ health 
behavior to fulfill the prescribed components (i.e., life style changes and improved 
adherence to the interventions’ components).     
Model domains 
We describe the optimized intervention domain, which includes the factors 
defining the multifaceted intervention: 1) Organizational factors (e.g., Interactive Voice 
Response System IVR) 2) Provider interventions (e.g., prescribed lifestyle change); and 
3) Patient Interventions (e.g., educational material).  The optimized evaluation domain 
includes factors that enhance the traditional effectiveness evaluations.  The mixed 
methodology in this thesis uses 1) semi-structured interviews to obtain the patients’ 
perspectives as determined in Aims 1 and 3 and 2) health behavior surveys to assess 
the association of the multifaceted intervention and specific constructs of patients’ health 
behaviors as determined in Aim 2. The populations in this thesis originate from 
multifaceted interventions.  
These interventions need appropriate evaluations that assess the various 
components as well as the overall effectiveness. Our intention is to evaluate the 
multifaceted interventions, understand which components the patients believe to be 
effective and assess the effectiveness of the combined intervention.  This objective is 
obtained by evaluating individual participants’ opinions and beliefs and how the 
intervention affected the outcomes such as patients’ health behavior to fulfill the 
prescribed components (i.e., life style changes and improve adherence to the 
interventions’ components).  The final step is to then apply the lessons learned in back 
into the study design that will improve the successful intervention and facilitate the 




REVIEW OF THE LITERATURE/BACKGROUND 
Literature Review 
The primary purpose of this literature review is to appraise papers that describe 
in-depth experiences of participating in technology facilitated, multifaceted cardiac 
interventions from the patients’ perspective and how the interventions affected their 
health behavior decisions. The secondary purpose is to examine articles that assess the 
effect interventions had on specific health behavior components and their association 
with cardiovascular outcomes. The literature search was conducted using two 
databases: MEDLINE and PubMed.  MEDLINE is the U.S. National Library of Medicine's 
(NLM) premier bibliographic database that contains references to journal articles in life 
sciences with an emphasis on biomedicine. MEDLINE records are indexed with Medical 
Subject Headings (MeSH). (41) PubMed is also a bibliographic database that includes 
MEDLINE, as well as, life science journals, and online books.  It also covers behavioral 
sciences, chemical sciences, and bioengineering. It is a free resource developed and 
maintained by the National Center for Biotechnology Information (NCBI) at the NLM, 
located at the National Institutes of Health (NIH). (42)   
The literature search is stratified into three main subject areas: cardiology, 
hypertension, and acute coronary syndrome.  MeSH terms were utilized in the PubMed 
and MEDLINE databases to identify literature relevant to the three stratifications plus 
additional relevant subjects including adherence, technology, qualitative analysis, and 
health behavior components: stages of change and self-efficacy.  The nine main MeSH 
terms include: 1) Cardiology, 2) Hypertension, 3) Acute Coronary Syndrome, 4) Patient 
Compliance OR Patient Adherence OR Medication Adherence; 5) Qualitative OR 
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Interview, 6) Interactive Voice Response, and 7) Blood Pressure Home Monitoring, 8) 
Stages of Change, and 9) Self-Efficacy.  
These terms were then combined appropriately to narrow each search.  All 
searches were limited to 1995 through March 2012 to capture investigations of patients’ 
perspectives of participating in multifaceted cardiac interventions and the assessment of 
the effect interventions had on health behavior components; specifically, stages of 
change and self-efficacy.  
Results of Literature Search  
Table 1 displays the results of the literature search, beginning with nine main 
MeSH terms then combining relevant topics to discern appropriate articles to this 
literature review.  The goal of the literature review is to identify and select articles that 
concentrate on each major subject area.  Article significance is determined by the 
relationship to one of the main subject areas in the outline and the search was narrowed 
to include specific articles that relate to the questions of this thesis.   
Individually, each of the major subject areas yielded the following citations: 
Cardiology 146,257; Hypertension 342,973; Acute Coronary Syndrome 13,897; 
Adherence 3,967; Qualitative OR Interview 224,166; and Interactive Voice Response 
319 of which 20 abstracts and 13 full text articles were reviewed.  Home Blood Pressure 
Monitoring yielded 9,663, Stages of Change 14,080, and lastly, Self-Efficacy 27,155 
citations. 
To narrow the search, Cardiology was combined with “interactive voice 
response” and three articles were reviewed to reveal one full text paper that was 
reviewed.  Next, cardiology was combined with “qualitative” or “interview” and 1,209 
articles were found.  Lastly, cardiology was combined with both “interactive voice 
response” and “qualitative” or “interview”; no citations were found.  
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Cardiology was then combined with adherence terms (Patient Compliance OR 
Patient Adherence OR Medication Adherence) where 542 citations were found, 40 
abstracts and 10 full text papers were reviewed.  Adherence was combined with 
technology where 167 citations were found, 48 abstracts and 5 papers were reviewed.  
Consequently, “qualitative” was added to the previous combination to yield 14 citations, 
of which two abstracts and one full text was reviewed.  Finally, “interactive voice 
response” was added to the previous search and no citations were found. 
For the final two Cardiology searches, cardiology was combined with “Stages of 
Change” and “adherence” where four citations were shown, four abstracts and two full 
text articles were reviewed.  Lastly, cardiology was combined with “Self Efficacy”, which 
narrowed the search to 14 citations, of which eight abstracts and two full texts were 
reviewed.  
Hypertension was combined with qualitative with 2,347 citations.  It was then 
combined with “Blood Pressure Home Monitoring” where 1,017 citations were found, 50 
abstracts were reviewed, and five full text articles were reviewed.  All three subjects 
were combined to narrow the search to 20 citations, five abstracts, and two full text 
articles, which were reviewed.  Hypertension was then combined with “Interactive Voice 
Response” with 11 citations, four abstracts and three full text papers reviewed.  Lastly, 
hypertension was combined with “Interactive Voice Response” and “qualitative” where 
one paper was cited and reviewed. 
Acute Coronary Syndrome was combined with “Interactive Voice Response”, two 
citations were found but neither was appropriate. Acute Coronary Syndrome was 
combined with “adherence” where 85 citations were revealed, 10 abstracts and two full 
texts were reviewed.  One hundred and twenty one citations were found when Acute 
Coronary Syndrome was combined with “qualitative”; eight abstracts were reviewed and 
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none were found to be relevant.  When all three subjects were combined, ACS, 
“adherence”, and “qualitative” five citations were found, of which two abstracts and full 
text articles were reviewed, yet, when “Interactive Voice Response” was added no 
citations were found.  The last two additions to the ACS search included adding “Stages 
of Change” to ACS and adherence where no citations were revealed and “Self Efficacy” 
was added to ACS and “adherence” with one citation, abstract, and full text was 
reviewed. 
Additional searches were performed to specifically look for the use of the 
validated health behavior surveys Stages of Change for Adherence with Medication 
(Willey et. al) and Self-Efficacy for Appropriate Medication Use Scale (SEAMS – Risser 
et. al) as evaluative tools in medication adherence interventions.  Therefore, self-efficacy 
was added to adherence and 1,755 citations were found.  When the survey was 
searched, 23 citations with one abstract and full text were reviewed. Lastly, Stages of 
Change and “adherence” were combined to show 155 citations, 20 abstracts, and eight 
full texts reviewed.  
 
Table 1. Literature Search History 






Cardiology 146,257   
Hypertension 342,973   
Acute Coronary Syndrome 13,897   
Adherence (Patient Compliance) 
OR (Patient Adherence) OR 
(Medication Adherence) 
3,967   
Qualitative OR Interview 224,166   
Interactive Voice Response  319 20 13 
Home Blood Pressure Monitoring 9,663   
Stages of Change 14,080   
Self-Efficacy  27, 155   
(Technology) AND (Qualitative OR 
Interview) 
10,782   
(Technology) AND (Qualitative) 6666   
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Table 1. Literature Search History  
(Technology) AND (Patients 
perspectives) and (Intervention) 
38 12 3 
(Interactive Voice Response) AND 
(Qualitative OR Interview) 
56 11 5 
(Technology) AND (Qualitative OR 
Interview) AND (HIV) 
220 20 4 
(Qualitative analysis) and (HIV 
Intervention) and (technology) 
7 5 2 
(Interactive Voice Response) AND 
(Qualitative OR Interview) AND 
(HIV) 
2 2 2 
(Cardiology) AND (Qualitative OR 
Interview) 
1,209   
(Cardiology) AND (Interactive Voice 
Response)  
3 3  1 
(Cardiology) AND (Interactive Voice 
Response) AND (Qualitative OR 
Interview) 
0 0 0 
(Cardiology) AND (Patient 
Compliance OR Patient Adherence 
OR Medication Adherence) 
542 40 10 
(Cardiology) AND (Patient 
Compliance OR Patient Adherence 
OR Medication Adherence) AND 
(Qualitative OR Interview)  
14 2 1 
(Cardiology AND (Patient 
Compliance OR Patient Adherence 
OR Medication Adherence) AND 
(Qualitative OR Interview) AND 
(Interactive Voice Response) 
1 1 1   
(Cardiology) AND (Stages of 
Change) AND (Patient Compliance 
OR Patient Adherence OR 
Medication Adherence)  
4 4 2 
(Cardiology) AND (Self Efficacy) 
AND (Patient Compliance OR 
Patient Adherence OR Medication 
Adherence)  
14 8 2 
(Hypertension) AND (Qualitative 
OR Interview) 
2,347   
(Hypertension) AND (Blood 
Pressure Home Monitoring) 
1,017 50 5 
(Hypertension) AND (Blood 
Pressure Home Monitoring) AND 
(Qualitative OR Interview) 
20 5 2  
(Hypertension) AND (Interactive 
Voice Response) 




Table 1. Literature Search History  
(Hypertension) AND (Interactive 
Voice Response) AND (Qualitative 
OR Interview) 
1 1 1  
(Acute Coronary Syndrome) AND 
(Interactive Voice Response)  
2 0 0 
(Acute Coronary Syndrome) AND 
(Patient Compliance OR Patient 
Adherence OR Medication 
Adherence) 
85 10 2 
(Medication Adherence) AND 
Technology 
167 48 5 
(Acute Coronary Syndrome) AND 
(Qualitative OR Interview) 
121 8 0 
(Acute Coronary Syndrome) AND 
(Patient Compliance OR Patient 
Adherence OR Medication 
Adherence) AND (Qualitative OR 
Interview)  
5 2 2 
(Acute Coronary Syndrome) AND 
(Patient Compliance OR Patient 
Adherence OR Medication 
Adherence) AND (Qualitative OR 
Interview) AND (Interactive Voice 
Response) 
0 0 0 
(Acute Coronary Syndrome) AND 
(Stages of Change) AND (Patient 
Compliance OR Patient Adherence 
OR Medication Adherence)  
0 0 0 
(Acute Coronary Syndrome) AND 
(Self Efficacy) AND (Patient 
Compliance OR Patient Adherence 
OR Medication Adherence)  
1 1 1 
(Self Efficacy) AND (Patient 
Compliance OR Patient Adherence 
OR Medication Adherence) 
1,755   
(Stages of Change) AND (Patient 
Compliance OR Patient Adherence 
OR Medication Adherence) 




Cardiovascular disease (CVD) is the single leading cause of death and disability 
in the United States, with one in three American adults (about 82,600,000) having one or 
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more types of cardiovascular disease and accounts for 33.6% of all deaths. (1, 2)   CVD’s 
are chronic conditions that are among the most costly health problems facing our nation. 
In fact, the estimated cost in 2010 was more than $444 billion, which includes lost 
productivity from deaths and disability and healthcare expenditures: this economic 
burden will become even greater as the U.S. population ages. (2)  It is estimated that by 
2030, 40.5% of the US population is projected to have some form of CVD. (1)  Therefore 
it is imperative to investigate interventions to ameliorate the effects of CVD and improve 
outcomes of patients with CVD. 
This thesis uses populations with hypertension and coronary heart disease, 
specifically acute coronary syndrome, to explore the proposed hypotheses and 
questions. 
Hypertension (HTN) is one of the major causes of cardiovascular morbidity and 
mortality worldwide.  HTN affects about 76.4 million people in the United States age 20 
and older and the prevalence increases with advancing age.  Yet, hypertension is only 
controlled to guideline recommended levels in 48-50% of the population who are aware 
that they have hypertension. (2,-24-25)  Treatment of hypertension involves medication 
therapy where appropriate and patients’ adherence to lifestyle changes and/or 
medications.  However, adherence rates are about 50% for medications and are much 
lower for lifestyle changes, significantly jeopardizing treatment success. (3-7)   
Treatment success is defined by the Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC 7) (43-45) who has classified blood pressure (BP) based on the average of two or 
more properly measured, seated readings on each of two or more office visits.  The 
classifications are: Normal is defined as systolic blood pressure (SBP) <120 mm Hg and 
diastolic blood pressure (DBP) <80 mm Hg; Prehypertension SBP 120-139 mm Hg or 
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DBP 80-89 mm Hg; Stage 1 Hypertension SBP 140-159 mm Hg or DBP 90-99 mm Hg; 
Stage 2 Hypertension SBP ≥ 160 mm Hg or DBP ≥100 mm Hg.  Patients with 
prehypertension who also have diabetes mellitus or chronic kidney disease, and whose 
SBP ≥ 130 mm Hg and DBP ≥ 80 mm Hg should be considered candidates for 
appropriate therapy. (43) 
Consequences of hypertension are well known and include: risk of heart attack; 
stroke; kidney disease; and death from both ischemic heart disease and stroke, which 
increases progressively and linearly with levels of hypertension.  Cardiovascular disease 
risk doubles for each increment of 20/10 mm Hg and is continuous, consistent, and 
independent of other risk factors. (43)  “It has been estimated that a 5 mm Hg reduction of 
the systolic blood pressure in the population would result in a 14 percent overall 
reduction in mortality due to stroke, a 9 percent reduction in mortality due to coronary 
heart disease, and a 7 percent decrease in all-cause mortality.” (43)  Thus, there is a 
public health incentive to reduce the prevalence and outcomes of hypertension in the 
United States.  Therefore, using this population to explore an in-depth understanding of 
the effects of multifaceted interventions expands the literature regarding the subjective 
perceptions of the mechanisms of a hypertension intervention.  
The second population of this thesis is Coronary heart disease (CHD), also 
called coronary artery disease (CAD).  CAD is caused by the atherosclerotic stenosis 
and occlusions of the coronary arteries.  In this complex process, plaques of cholesterol 
and other waste products build up in the linings of the heart arteries, causing blockage of 
blood flow to the heart.  Oxidized low density lipoprotein (LDL) is the basis for the 
cholesterol build up and the initiator of the inflammatory response, which eventually 
calcifies arteries causing the narrowing and hardening of the arteries (stenosis).  As this 
process continues, blood flow is inhibited, preventing oxygen rich blood from reaching 
18 
 
the myocardium (ischemia) leading to symptoms such as chest pain (angina).  This 
process also causes the arteries to become vulnerable to injury and tears.  The end 
result of this process may be a myocardial infarction (MI) or death if the blockage is 
complete. (44-45) 
Patients who present with a myocardial infarction (MI) or unstable angina (UA) 
are defined with the term of “acute coronary syndrome” (ACS).  MI symptoms are 
classified and treated clinically into categories based on the presence of ST segment 
elevations myocardial infarction (STEMI) or absence of ST segment elevations 
(NSTEMI) on the presenting ECG and abnormal elevations of myocardial biomarkers 
(i.e. troponin). (44-46)  UA is defined as chest pain or discomfort that is accelerating in 
frequency or severity and may occur while at rest but does not result in myocardial 
necrosis. (1)  Consequences of ACS may lead to death, heart failure, or life-threatening 
arrhythmias.  To improve outcomes, treatment of ACS, after the initial hospital 
management, involves medication therapy and lifestyle changes.  However, non-
adherence to proven cardio-protective medications contributes to the persistently high 
risk of adverse outcomes following ACS hospitalization. (47) Consequently, it is important 
to investigate interventions that ameliorate the effects of ACS, such as improving 
adherence to medication regimens and prescribed life-style changes. 
Accordingly, prevention of CVD by ameliorating causes, such as hypertension, 
and improving CVD outcomes, following ACS, is imperative if we are to improve 
morbidity and mortality rates in the United States.  Using multifaceted interventions and 
further exploring patients’ health behavior changes that may have occurred during the 
study may improve the overall effectiveness of the interventions. Improving the 





Treatment of CVD usually involves medication therapy and lifestyle changes. 
Successful treatment of CVD depends in part on patients’ health behavior, such as their 
adherence behavior.  Health behavior theories indicate that personal factors, (e.g. self-
efficacy and stage of change) and environmental factors, (e.g. relationships with their 
family, friends, and health care providers), influence each other and ultimately affect 
patients’ health outcomes such as adherence to lifestyle changes and adherence to 
medications. (28, 39 40)  Current adherence theories are more successful in explaining non-
adherence than improving adherence. (5-9)  Numerous studies addressing adherence in 
the general population have found adherence rates are about 50 percent for medications 
and are much lower for lifestyle modifications. (3-7, 48-50)  The World Health Organization 
has categorized potential reasons for medication non-adherence into five broad 
groupings, including: health system, condition, patient, therapy, and socioeconomic-
related factors. (50)  In comparison to patients with acute conditions, patients with chronic 
conditions have been shown to have lower adherence rates with the most dramatic drop 
in adherence being noted after the first six months of therapy. (6)  Therefore, 
understanding health behavior theory is important to understanding patients’ adherence 
behavior to interventions intending to improve clinical outcomes. 
In an effort to explain and understand health behaviors academicians have 
constructed multiple health behavior theories, yet, none are mutually agreed upon.  One 
health behavior model is the Transtheoretical Model (TTM), which focuses on the 
decision-making abilities of the individual.  This model includes four main constructs: the 
stages of change, processes of change, self-efficacy, and decisional balance. (27-31)  TTM 
is a systematic integration of multiple theories and conceptualizes behavior change as a 
process that unfolds over time where the person progresses through five stages of 
20 
 
change: pre-contemplation, contemplation, preparation, action, and maintenance.  
Relapse prompts a cyclical movement back through the initial stages.  The stages signify 
a period of time and represent when people change. (27-31) 
Pre-contemplation is the stage where patients have no intention of changing 
behavior in the foreseeable future, such as the next six months.  Patients are unaware or 
under-aware of the consequences of their behavior, or patients may have failed attempts 
to change and are discouraged to try again. (27-31)   
Contemplation is the stage in which patients are aware of a problem and are 
intending on making a change within the next six months but have not yet made a 
commitment to take action.  Contemplators are weighing the pros and cons of their 
dysfunctional behavior against changing their behavior. (27-31)   
Preparation is when patients are intending to make a behavior change within the 
next month and are making some small behavioral changes.  Patients may move to the 
next stage after they have selected a plan of action and are confident they can follow 
through with the plan. (27-31)   
Action is the stage in which patients have made efforts to modify their behavior, 
experiences, and/or their environment within the last six months to address their 
dysfunctional behavior.  Action requires significant behavior changes and requires 
commitment of time and energy. (27-31)   
Maintenance, the final stage, begins after the Action stage and extends 
indefinitely.  The patient works to prevent relapse and consolidate the gains made in the 
Action stage.  Patients are less tempted to relapse and more confident in maintaining 
their positive health behavior. (27-31)   
The second construct, processes of change, describes how people change.  
Change processes are cognitive and behavioral activities that are used to progress 
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through the stages of change.  Ten processes identified with the most theoretical and 
empirical support has been assembled based on principal components analysis. (27)  The 
first five processes are experiential and include: consciousness raising, dramatic relief, 
self-reevaluation, environmental reevaluation, and self-liberation and are used in the 
early stages.  The last five processes are behavioral and are most useful during the 
latter stages and they include: social liberation, counter conditioning, stimulus control, 
contingency management, and helping relationships.  Exploring and understanding the 
specific processes and the movement of stage of change adds to the assessment of 
health behavior components. (27-31) 
Stages of change are also related to self-efficacy, which is described as the 
confidence to cope with stressful situations and not relapse to unhealthy behavior.  The 
patient must have the capability to perform the appropriate behavior and have the 
perception that a positive outcome will occur.  Self-efficacy is a critical factor that 
determines a person’s behavior change and may be a main cognitive barrier to 
adherence. The self-efficacy construct integrated into the TTM is based on the research 
by Albert Bandura who first identified the significance of self-efficacy and behavioral 
change. (27-31, 51-52)    
The last construct of TTM is decisional balance, which refers to patients weighing 
the benefits and costs of changing their behavior.  Decisional balance varies through the 
stages of change and has been demonstrated to be a good predictor through the stages. 
(27)     
To fully understand the integration of the TTM model and the study design 
proposed, one must acknowledge the strengths and limitations of integrating the two.  
Health behavior models define what to measure and therefore, are inherently linked to 
the measurements defined. (53)  Each theoretical model describes health behavior using 
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unique concepts and verbiage.  TTM describes behavior change as a process, broken 
down into stages, which are able to evaluate specific variables associated with that 
stage. (53)  TTM works well with research and interventions because of its individualized 
design, which integrates well with our study design. (53)   
Yet, the weakness of the study design and the health behavior model integration 
is the inability to assess the thought process of how people change their behavior.  This 
cannot be appropriately assessed by either quantitative or qualitative measurements due 
to the fact that most people are not consciously aware of their reasoning.  Thus, when 
we assess their level of stage of change with the SOC survey, we have a “value” of their 
motivational level, but not their thought process.  For example, saying that they like the 
IVR because they need external motivation from the IVR calls or persuasion from the 
study personnel.  
The ultimate strength of this study is the mixed methodology design, which 
utilizes triangulation and allows researchers to better understand subtleties, as well as 
cross-validate findings that we are able to assess. (54) 
Mixed methodology utilizing inductive (emerging from the ground up, originating 
from data obtained by observation or open-ended responses and develops into an 
understanding by the researcher) and deductive (starting with extant hypotheses, 
theoretical frameworks) thinking in conjunction with quantitative assessments allows 
researchers to better understand patients’ health behaviors and tease out factors that 
support positive health behaviors. (33, 55-57)  Triangulating qualitative data with quantified 
self-identified, self-efficacy measures of adherence along with assessing readiness to 
change adherence behavior strengthens the validity and analytical rigor of this thesis.  
Therefore, this thesis uses the TTM to understand and explore two specific 
constructs of patients’ health behavior: The cycle of where patients are in the stage of 
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change and their level of confidence.  Additionally, this thesis assesses if those factors 
are associated with their ability to follow through with the prescribed health behaviors 
and whether or not the technology facilitated intervention influenced changes in the 
patients’ health.  In addition, the information may help explain some of the variability in 
the effectiveness of interventions. 
Technologies  
In the last decade communication and monitoring technology have become a 
significant part of health care and are likely to play an important part in supporting 
patients to become more informed and activated to improve health outcomes and reduce 
costs. (56)  Interactive voice response (IVR) technology and blood pressure home 
monitoring are successful technologies in cardiac care. (8-25)  IVR is a computer-based 
telephone system which initiates calls, receives calls, provides information, and collects 
data from users. IVR systems are comprised of three components: 1) a standard 
microcomputer, 2) specialized hardware that interfaces with telephone systems to place 
calls, and 3) software that controls the calling operations. The hierarchically structured 
messages are composed of statements and queries that determine the process of the 
calls sent and received.  The IVR system does not require any specialized 
communication platforms, such as the Internet and therefore can be implemented 
rapidly.  The data collected from patients using the telephone touch pad are stored and 
may be used to generate graphs and charts for analyses or reported back to the patients 
for their review. (58-59)  Most patients report that they are willing to participate in IVR-
based technology programs and some form relationships with the technology. (11, 14, 60-64)    
The IVR system has been used for disease management, conversing with 
patients between doctor office visits, home monitoring, ordering medications, 
educational messaging, administration of questionnaires and surveys, medication refill 
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and appointment reminder calls, and is a conduit to valid, reliable and clinically 
meaningful information about the patient’s health status. (8-25) 
Home blood pressure (BP) monitoring, using validated devices, is recommended 
by the American Heart Association (65) and has been shown to lead to greater BP 
reduction when compared to usual care up to 12 months when used in combination with 
clinical support modalities. (66)  In addition to monitoring the effects of treatment, 
increasing evidence indicates that home BP readings predict cardiovascular events. (62)  
Lastly, use of home blood pressure monitoring has been shown to increase patient 
involvement in the management of their hypertension and produce beneficial changes in 
their health behavior. (12-13)   
Multifaceted interventions incorporating telehealth technologies such as 
telephonic interactive voice response (IVR), voice messaging, and electronic home 
monitors have been shown to improve cardiovascular outcomes.  Yet, few studies using 
IVR and home BP monitoring investigate the patients’ perspective of the intervention, the 
mechanics, their feelings about the intervention, and how it affected their health 
behavior.  The knowledge of their perspective is integral to understanding the 
interventions outcomes.   
Methodologies 
To understand the effectiveness of technology facilitated interventions from the 
perspective of the participant, as well as the association of specific health behavior 
constructs and these interventions, a mixed methodology analysis is employed. 
The mixed methodologies used in this study include quantitative and qualitative 
analyses.  Quantitative approaches alone are not well suited to examine complex 
aspects of healthcare such as adherence behavior, decision-making processes, and 
patients’ perceptions of quality of care.(34) Qualitative methods are better suited to 
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understand complex social processes, capture patients’ perspectives of the 
phenomenon being investigated, and to explore beliefs, values, and motivations that are 
the basis of health behaviors.(34,57,67)   Using both methodologies and multiple populations 
is a concept of triangulation, which is a technique that strengthens the validity of the 
study. (36, 57) 
Triangulating with both quantitative and qualitative methodologies employs skills 
in observation and recording numbers. This allows for a more natural and practical 
research approach because complex behaviors are more thoroughly explained with both 
numbers and words. (36, 54) The purpose of triangulation is to test for consistency. 
Understanding inconsistencies from different types of data that are sensitive to 
alternative aspects of the phenomenon in question offers deeper insight into the 
relationship between the inquiry approach and the phenomenon. (56) Utilizing both 
inductive and deductive thinking allows researchers to better understand patients’ health 
behaviors and tease out factors that support positive health behaviors. (33, 55-57)  
Triangulating qualitative data with quantified self-identified self-efficacy of adherence and 
assessing readiness to change adherence behaviors strengthens the validity and 
analytical rigor.  By combining the two data gathering techniques, researchers are able 
to clarify subtleties as well as cross-validate findings. (36)  In addition, by using mixed 
methods, it is possible to investigate whether/how data from patient interviews and 
standardized instruments converge or depart. This may give further insight into patients’ 
health behaviors. (36)  
Objective and subjective coding scheme and analytic techniques, content 
analysis and grounded theory, are used to assess the qualitative findings.  Content 
analysis has been defined as, “any qualitative data reduction and sense-making effort 
that takes a volume of qualitative material and attempts to identify core consistencies 
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and meanings,” (56) and “a research method for the subjective interpretation of the 
content of text data through the systematic classification process of coding and 
identifying themes or patterns.” (68)  Both quantitative and qualitative forms of content 
analysis exist. Some methodologists believe in blending the two, resulting in counting 
themes and patterns derived from both inductive and deductive reasoning. (69)  
The constructionist methodology of Grounded Theory approaches are utilized to 
investigate the experience of having an ACS event and conceptualize the latent patterns 
and structures of the process and consequences.  Grounded Theory is the systematic 
generation of theory from systematic research.  It is a set of rigorous research 
procedures leading to the emergence of conceptual categories.  These 
concepts/categories are related to each other as a theoretical explanation of the 
action(s) that continually resolves the main concern of the participants in a substantive 
area.” (70-71)  A constructionist perspective focuses on the subjective interrelationship 
between the researcher and the patient and the interrelated construction of the 
meanings of the analyses. (71)  The objectives of theory generation in grounded theory 
can be explanative and predictive, based in the positivist framework, as well as, 
understanding and interpretive, based in the interpretive philosophy. (71)   The pragmatic 
framework of this thesis and following the constructivist perspective allows utilization of 
both methodologies to derive the theory. 
This thesis utilizes a blending technique of the two qualitative methodologies 
using inductive and deductive analyses, as well as objective and subjective perspectives 
to obtain the most robust findings.  
The approach used to integrate the quantitative and qualitative data is a merging 
data approach.  This approach is achieved by reporting the two types of data together 
and is presented in the discussion section of the thesis. (54) 
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Gaps in the Literature 
Cardiac Technology Facilitated Interventions and Pa tients’ Perspectives 
The literature review identified several papers that are closely associated to the 
questions and hypotheses stated in this thesis addressing the importance of 
understanding, from the perspective of the patient, how technology affected their cardiac 
care and health behaviors.   
Friedman et al. (17) were pioneers in 1996 utilizing a telecommunications system 
to monitor and counsel hypertensive patients.  Using a telephone based system they 
were able to monitor self-report home BP results, medication adherence, medication 
knowledge and side effects.  The telecommunication system also provided education 
and motivational counseling to improve adherence.   
The randomized control trial found significant differences between the 
intervention and the usual care groups for the primary and secondary outcomes. 
Patients’ attitudes and reactions to the telephone based system were obtained using an 
a priori structured interview of the system with a 5-point Likert scale and an overall 
satisfaction question using a visual analog scale.  
Yet, as previously stated, interventions work through the patients’ reasoning.  
Knowledge of that reasoning is integral to understanding the interventions outcomes and 
using only deductive assessments of the patients’ perspectives falls short of the 
expansive investigational ability that inductive qualitative inquiry can unfold.  Inductive 
qualitative inquiry can explore how and why phenomena occurred and it can determine 
how patients interpret specific constructs, such as self-esteem. (35)  Since the data is 
based on the patients’ own meanings it can describe in rich detail how an intervention 
functions or not in a local context. (35)   
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Therefore, Friedman et. al missed an opportunity to gather information that could 
have given insight into the reasons for the success of their study and guide 
implementation into standard clinical practice. 
Piette et al. (15,16, 72) were also at the forefront using IVR technology in various 
chronic diseases and continue to lead innovative applications. Yet, they too used 
quantitative surveys to assess patient centered outcomes and thus were unable to fulfill 
these gaps in the assessment of interventions by not considering patients’ perspectives 
of the difficulty of behaviors required by those receiving the intervention.  Thus missing 
the importance of going beyond evaluating overall effectiveness to understanding the 
component processes and how they vary among patients. 
One paper that did use an open-ended qualitative inquiry was Reidel et al.’s  (22) 
pilot non-randomized study that used an IVR system to improve medication adherence 
in chronic diseases.  The pilot was terminated because of technical problems with the 
phone system.   
A qualitative analysis was employed to obtain facilitators and barriers of the IVR 
system use through a structured survey that focused on the technical aspects of the 
system.  Open-ended questions were asked to investigate the participants 
understanding of the purpose and usefulness of the calls and the identified population 
used in this study may not have been in need of IVR medication reminders.  Hence, the 
qualitative inquiry enabled this pilot to be informative and add to the literature by 
identifying specific barriers to implementation of an IVR system.  
Consequently, the literature was lacking a study that assessed a randomized 
control trial from the perspective of the patient and evaluated how technology is affecting 
their cardiac care and health behavior, until the publication of Lambert-Kerzner et al., 
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“Patients’ Perspectives of a Multifaceted Intervention with a Focus on Technology: A 
Qualitative Analysis” in 2010, (25) which fulfilled Aim 1 of this thesis. 
Until February of 2012, our study was the single investigation that used in depth 
qualitative inquiry to explore patients’ experiences of a CVD intervention.  Jones et al. (73) 
used a qualitative constant comparative methodology to explore the reasoning of the 
patients behavior during the TASMINH2 (14, 73) trial.  This study evaluated a self-
monitoring system and self-titration of their medication in a hypertensive population.  
Researchers found that patients were confident about self-monitoring of their blood 
pressures and felt their home readings were more valid than the office readings.  Mixed 
findings were reported regarding patients’ confidence with self-titration.  Although many 
patients were confident with the self-monitoring, few wished to continue with a self-
management plan after the study. (73) 
Health Behavior Constructs as Evaluative Tools 
One of the main determinants of treatment success of CVD is dependent on 
patients’ health behavior. It is important to understand if there is an association between 
specific constructs of health behavior and CVD outcomes such as improved adherence, 
especially if the intent of an intervention is to modify behavior.  Investigation of specific 
constructs (ie. stage of change and self-efficacy) could shed light on whether or not the 
intervention influenced such changes. 
Therefore, the literature search looked for papers that addressed these specific 
constructs as evaluative tools when assessing interventions.  Studies that specifically 
used the health behavior constructs of stages of change and self-efficacy were 
searched.  Specific tools to evaluate self-efficacy and stage of change in medication 
adherence are limited and include Willey’s “Stages of Change for Adherence with 
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Medication Regiments for Chronic Diseases” (74) and Risser’s Self-Efficacy for 
Appropriate Medication Use Scale (SEAMS) survey.  (75) 
Dr. Kripalani one of the authors of the SEAMS scale, used it in the piloted 
randomized control trial “The Improving Medication Adherence through Graphically 
Enhanced Interventions in Acute Coronary Syndromes (IMAGE-ACS)” study (76) that he 
presented as an abstract at the Health Literacy Annual Research Conference.  At 
discharge ACS patients were randomized to the literacy intervention and the baseline 
surveys.  Follow-up with phone administered surveys occurred one to two weeks later.  
As described in the abstract, the results of their study indicate that the intervention 
showed a significant improvement in self-efficacy in the intervention group compared to 
the usual care group.  No other published studies were found that used this survey as an 
evaluative pre-post tool.  
Most studies use TTM theory to individualize medication adherence interventions 
and some used a SOC survey as an evaluation pre-post tool. (77-80) Johnson et al (79) 
investigated adherence to both antihypertensive and lipid lowering drugs using an 
individualize SOC intervention and evaluated the movement between stages, which 
were significant. (78-79)  
One study examined patients’ readiness for substance cessation and 
psychotropic medication adherence on admission to a residential substance abuse 
treatment program and again 30 days after discharge. (80)  The study did not include a 
stage of change intervention in the program but assessed patients SOC using the same 
survey we are using.  Therefore, this paper is the only study found to use the survey as 
an evaluation tool without including the stage of change concept in the intervention, 
which is exactly how we are using the SOC survey.  The study is not a CVD study and 
they were unable to evaluate individual movement between the stages only the 
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proportion of patients in each stage pre and post.  Thus, there are no studies found that 
address the proposed hypothesis using these specific tools in the cardiovascular 
population.  
Therefore, the proposed research is needed to address the following gaps in the 
literature: 1) patients’ perspectives of their cardiac care using technology, specifically of 
an intervention to improve medication adherence, 2) investigation into the association of 
a cardiac intervention on the health behavior construct of stage of change (SOC) using 
individual data and the association with adherence outcomes, 3) investigation into the 
association of a cardiac intervention on the health behavior construct of self-efficacy ) 
using individual data and the association with adherence outcomes. 
To date, no studies found explore the complex nature and interplay of patients’ 
perspectives of cardiac care interventions using technology and health behavior 
constructs with a mixed methodology.  Although quantitative studies are abundant in 
cardiac literature, none use a mixed methods approach to understand the complexity of 
this phenomenon.  
Patients’ Perspectives of Technology Facilitated Ca re Outside Cardiology 
Patients’ perspectives of their experiences with interventions that include 
technology are uncommon in the literature for cardiology as well as other disease states.  
Sixteen papers were found, outside of cardiology that initially appeared to be applicable, 
yet only five were appropriate and will be included in this review.  None of the studies 
were randomized control trials (RCTs).  Two studies randomized the subjects into two 
different interventions but neither used control groups.  Two papers evaluated non-
randomized interventions using web-based tools.  One addressed improving older 
adults’ experience with IVR systems.   
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A focus of this thesis investigates patients’ perspectives of IVR technology and 
most of the subjects in the studies are from the Veteran’s Affairs (VA) population where 
the average age is approximately 65 years of age.  Therefore, Miller et. al’s paper 
“Improving Older Adults’ Experience with Interactive Voice Response Systems” (81) is of 
interest.  The aim of the study was to identify areas of difficulty in IVR use and to 
propose strategies for improvements.  The most common difficulties included: 
confusing/difficult instructions and being cut off for not responding fast enough or making 
a mistake.  Additional complaints included voices speaking too quickly, too many options 
to choose from, and having to provide the same information multiple times.  They did, 
however, report that the IVR systems were patient – meaning that they were able to 
have the information repeated multiple times.   
The ideal system was described using the following themes: friendly, polite, with 
short, clear, and unambiguous instruction.  Patients would like the ability to adjust the 
volume and the speed of the conversation.  They wanted to remove patronizing phases 
such as “Good job;” additionally, if a break was needed, patients wanted to be able to 
pause the process and not have to start over.  The authors concluded that improving the 
design of IVR algorithms to detect difficulties during an ongoing IVR exchange and 
individualizing algorithms may increase the acceptability of the systems with older 
adults.  
Recently, communication and monitoring technology have become a significant 
part of health care and are likely to play an important part in supporting patients to 
become more informed and activated to improve health outcomes and reduce costs. (56)  
Interactive Voice Response technology has become a useful tool in the process.  
Therefore, Miller et. al’s study is important and informative and may be interesting to 
compare and contrast the findings of this thesis with Miller et. al’s findings.  
33 
 
“Personal relationships with an intelligent interactive telephone health behavior 
advisor system: a multimethod study using surveys and ethnographic interviews” (64) was 
a two arm randomized trial that compared two Telephone-Linked Care (TLC) health 
behavior change programs.  One arm promoted regular physical activity and the other 
healthy eating.  Kaplan et. al were pioneers in 2003 using a qualitative approach to 
assess the patients’ perspectives.  The grounded theory analysis revealed that patients 
formed personal relationships with TLC in three different ways: 1) They expressed 
feeling of love, 2) They expressed feelings of guilt, and 3) They expressed feelings of 
ambiguity or ambivalence over whether they were talking to a machine or to a person. 
The findings of this innovative study design implemented in 2003, using 
quantitative and qualitative inquiry, illustrates why attitudinal surveys alone are not able 
to understand participants’ reactions to technology.  The authors were able to 
understand why people had the reactions shared in the quantitative surveys and what 
accounted for their different reactions.  The authors also indicate that more work was 
needed to “understand the phenomena of relationship formation with technologies, of 
how these relationships reflect projections of values and goals, and of how both of these 
affect health behavior change.”(64) 
McTigue et. al’s (82) investigation into patients’ perceptions of an online behavioral 
weight loss intervention in a primary care setting found that the program improved 
communications with primary care physicians (PCPs).  The study found that interactions, 
which acknowledged patients’ efforts to change lifestyles and / or offered 
encouragement and support, were positively received.  Other patients spoke of the 
positive coordination of the program with their health care.  In conclusion, the authors 
indicated that online technology may be helpful for self-management and improved 
clinical counseling in the primary care setting. 
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Although interesting, McTigue et. al’s paper did not delve into the participants 
perspective of the technology of the online program.  Yet, it may be interesting to 
compare McTigue et. al’s findings to this thesis in regard to patients perceptions of how 
technologies improve relationships with their providers. 
m-Health and e-Health are two new forms of incorporating technology into the 
practice of medicine and public health.  The two most recent papers explore the patients’ 
perspectives when using these technologies in the HIV population.  “Challenges in Using 
Mobile Phones for Collection of Antiretroviral Therapy Adherence Data in a Resource-
Limited Setting” by Haberer et. al. (83) investigated the use of cell phones, IVR 
technology, and short message service (SMS) text messaging to collect adherence data 
in children’s’ caregivers in Mbarara, Uganda.   
Qualitative findings revealed typical issues of using a cell phone such as 
technical challenges using the phones, keeping the phones charged, calls being 
dropped, and forgetting to have their phones with them at all times.  The emerging 
themes identified a poor understanding of how to respond to the IVR or SMS prompts.  
Challenges in training indicate that participants are hesitant to acknowledge a lack of 
understanding during the sessions and suggest that repeated training sessions over time 
may improve the response rates and data collection.  Yet, all participants said the 
technologies are acceptable and some felt that the calls and text messages served as 
adherence reminders. 
The final paper examined was “Consumer e-health education in HIV/AIDS: a pilot 
study of a web-based video workshop” by Laura O’Grady. (84)  The qualitative study 
assessed HIV/AIDS patients’ feedback of an integrated web-based consumer health 
education environment.  Overall, the participants did not find the forum to be of value for 
learning about treatment information.  They indicated that the structure was not well 
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organized and that there was too much information.  Technical problems and specific 
issues of techniques used by the workshop presenter were also identified.  Constructive 
comments shared specified that individual learning styles were nicely addressed in the 
workshop with multiple forms of information provided (written documents, videos, or 
audios).  
The results of this study indicate that although the practice of medicine desires 
and utilizes technology, there may be too much of a good thing at work.  Further 
research is needed to assess where and when this type of technology may be 
warranted.  
The additional literature search to assess participants’ perspectives of technology 
facilitated care outside of cardiology revealed that the patients’ perspective is also rare in 
other conditions.  Few studies have assessed the perspective of the participants in their 
evaluation of interventions even though it has been identified as an essential element for 
an effective assessment.  Theoretical and empirical frameworks support the importance 
of exploring subjective views when assessing effectiveness. (37-38)  As previously stated, 
patients choose to participate in interventions and choose to execute the prescribed 
behaviors.  They also have the option of not doing what has been requested or 
modifying the behavior in a way that changes the integrity of the intervention.  Therefore, 
knowledge of patients’ choices and understanding the reason behind their decisions may 




STUDY HYPOTHESES, RESEARCH METHODS AND ANALYSIS PLA N 
Overview of Study Hypotheses, Research Methods, and  Analysis Plan 
The primary purpose of this thesis is to gather an in-depth understanding of the 
experience of participating in technology facilitated multifaceted cardiac interventions 
and to appreciate from the patients’ perspective how the interventions affect their health 
behavior decisions.  
The secondary purpose is to assess the association of technology facilitated 
interventions on cardiovascular outcomes mediated by specific health behavior 
components. 
To accomplish the defined goals a mixed methodology analysis is employed.  
The qualitative analyses incorporate an iterative, inductive and deductive toolkit of 
analytical strategies, drawing on multiple types of analyses.  Both univariate and 
multivariate quantitative analyses assess possible associations between the health 
behavior variables and outcomes.  
 
Aim 1: Gather an in-depth understanding of the phen omena of participation in a 
pharmacist lead, multi-faceted intervention of hype rtensive patients using an 
Interactive Voice Response System and Home Blood Pr essure Monitor  
Rationale 
In an effort improve cardiovascular outcomes, multifaceted interventions 
targeting healthy behaviors and medication adherence have been employed.  To fully 
understand the effectiveness of these interventions it is important to obtain and assess 
the patients’ perspective of their experience.  In addition, the evaluation needs to 
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understand what the patient perceives to be effective components of the multifaceted 
intervention. 
The literature search found no studies that addressed the proposed question.  
Therefore, this research is needed to speak to this important gap in the literature. 
Objective 
What are patients’ perspectives of participation in  a multifaceted 
intervention? 
• Specific Aim 1: Use semi-structured, one-on-one qualitative interviews to gather 
the participants perspective of the effectiveness of the multi-faceted intervention. 
• Specific Aim 2: Use semi-structured, one-on-one qualitative interviews to gather 
the participants perspectives of the impact of the intervention on their health 
behavior. 
• Specific Aim 3: Propose a theoretical model of a hypertension management.   
Design 
Participants in the “Improving Blood Pressure in Colorado” a randomized control 
study (9, 18, 25) are interviewed for this Aim.  The study investigates the use of a 
pharmacist-led multifaceted intervention to improve blood pressure (BP) control, using 
an IVR system, a home blood pressure monitor and patient education.  Using the IVR 
system, patients report their home BP results on a weekly basis.  The IVR system 
averages the measurements and provides feedback to the patient about their level of 
control.  If patients do not report BP measurements to the IVR system after 11 days, the 
IVR system delivers reminder calls to patients.  The pharmacists receive reports on 
patients’ home measurements and work with the patients through in-person or telephone 
visits to achieve blood pressure goals.  In addition, the IVR system allows patients to 
request a call from the pharmacist, connect to the pharmacy refill line or the nurse line, 
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or listen to educational messages.  Patients in both arms receive an educational booklet 
on hypertension as well as comprehensive education on hypertension (e.g., diet, 
exercise). (9, 18, 25) 
Subjects 
One hundred and forty-six participants of the “Improving Blood Pressure in 
Colorado” a randomized control study (9, 18, 25) are interviewed for this Aim.  The patients 
are enrolled from the Denver Veterans Affairs Medical Center and the Denver Health 
Medical Center. 
Inclusion criteria include patients with uncontrolled hypertension defined as 
elevations in two of the three most recent electronic BP measurements (>140 mm Hg for 
systolic or >90 mm Hg for diastolic; for patients with diabetes mellitus or chronic kidney 
disease, >130 mm Hg for systolic or >80 mm Hg for diastolic), taking four or fewer 
antihypertensive medications, and are greater than 17 years of age. (18, 25) 
During the last study visit, the patients are interviewed about their experience 
with the multifaceted intervention.  
Data  
During the last study visit, patients are interviewed about their experience with 
the study to gather in-depth understanding of the phenomena of participation in a multi-
faceted intervention.  Due to issues such as illiteracy, cultural barriers, and prior 
experience with low response rates with surveys, qualitative interviews were chosen to 
investigate patients experience and their opinion of the effectiveness of a multifaceted 
intervention.  The data are collected in-person, using semi-structured, one-on-one, open-
ended interviews. We chose questions that addressed each component of the patients’ 
overall experience during the study and the effect of the study on the patients’ health 
behavior. (9, 18,25) 
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The interview guide includes 16 semi-structured, open-ended questions that 
address general items for both arms of the study such as: details about taking their 
medications and any difficulties and the effect of the study on their health behaviors.  
Additionally, the intervention group are asked specific questions about their experience 
with the following: 1) Details regarding taking their BP readings at home and any issues 
they experienced; 2) Utilization of the IVR system to include details of the various 
components of the system and any problems; 3) Working with the study pharmacists 
and the effects on their BPs, medication adherence, and overall health; and 4) The 
effects of participation in the BP study on their health behavior and utilization of 
healthcare. (25) 
Study staff conduct and audio-tape the interviews, which ranged from 40 to 60 
minutes.  The audiotapes are transcribed verbatim.  This qualitative study was approved 
as part of the randomized controlled trial by the Colorado Multiple Institutional Review 
Board. (25)  
Baseline demographics including age, sex, race, ethnicity, socioeconomic status 
(SES), marital status, and highest education level are obtained to characterize the study 
population.  
Analysis 
• Specific Aim 1: Use an iterative, inductive and deductive toolkit of analytical 
strategies, drawing primarily on qualitative content analysis and consultative and 
reflexive analysis to assess the participants’ perspective of the effectiveness of 
the multi-faceted intervention. 
• Specific Aim 2: Use an iterative, inductive and deductive toolkit of analytical 
strategies, drawing primarily on qualitative content analysis and consultative and 
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reflexive analysis to assess the participants’ perspective of the impact of the 
intervention on their health behavior. 
• Specific Aim 3: Use an iterative, inductive and deductive toolkit of analytical 
strategies, drawing primarily on qualitative content analysis and consultative and 
reflexive analysis to generate a theoretical model of a hypertension 
management.   
An iterative, deductive and inductive toolkit of analytical strategies, drawing 
primarily on qualitative content analysis, and consultative and reflexive analysis is used 
for the analyses.  All transcripts are analyzed by the first author and random transcripts 
are analyzed by one of the research assistants using qualitative content analysis 
methods. (25, 68, 85-87)  The analysis begins with repeated readings to achieve immersion 
(25, 68) followed by initial coding using an emergent rather than an a priori approach, in 
order to emphasize respondent perspectives and de-emphasize researchers’ 
assumptions. (25, 86)  Subsequent analysis uses a deductive approach to capture the 
essence of the impact of the multifaceted intervention.  Words, sentences, and 
paragraphs are treated as coding units or “meaning units”. (25, 87) 
After the initial coding is complete, codes are compared and reconciled and 
emergent themes are identified through intersubjective agreement, and are then 
presented to a senior qualitative analyst for review.  Throughout the analysis, the 
findings are continually checked and compared with the rest of the data in order to 
determine new codes, themes or patterns. (71)  The preliminary results are reviewed by 
members of the thesis committee, to assess their evocativeness, thoroughness, and 
comprehensiveness. (88)  For analytical rigor, the senior qualitative analyst completes a 
final review.  The accountability of the results is supported by confirming patient reported 
use of the IVR system among those randomized to the intervention (25, 33, 71, 89) and also 
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with an investigation of an association between participants’ self-report of a positive 
impact of the intervention and achieving blood pressure goals.   
Outcome Measures 
An analytic summary of the interviews was written and published. (25)  In the 
publication, patients' own words and narratives were presented to preserve the tone and 
emotion of the patients’ experiences and increased the theoretical depth of the final 
description. In addition, a theoretical model of a hypertension management was 
presented in the paper. (25, 85)   
 
Aim 2: Assess the association of technology facilit ated interventions on 
medication adherence mediated by health behaviors 
Rationale 
In an effort to improve cardiovascular outcomes, multifaceted interventions 
targeting healthy behaviors and medication adherence have been employed.  
Understanding how the interventions affect health outcomes, such as medication 
adherence, is important to the overall success of the intervention.  In addition, 
understanding if and how these outcomes are modified by health behaviors may shed 
further light on how the intervention affected the outcomes. 
We have chosen the Transtheoretical Model of Behavior Change (TTM) (27-31) to 
explore if health behaviors modify the cardiovascular outcomes.  The TTM focuses on 
the decision-making abilities of the individual and will help us clarify the effects of the 
intervention on patients’ health behavior.  Investigation of specific constructs of TTM 
(self-efficacy and stage of change) may shed light on whether or not the intervention 
influenced changes in the patients’ health behavior, which ultimately may affect the 
outcomes of medication adherence. To evaluate the health behavior constructs, we have 
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employed the Self-Efficacy for Appropriate Medication use Scale (SEAMS) (75) and 
Stages of Change (SOC) (74) questionnaires for self-efficacy and stage of change 
constructs respectively.   
In the literature search, no studies were found that address the proposed 
hypotheses using these specific tools. Therefore, this research is needed to address this 
important gap in the literature. 
Objectives 
Multi-faceted points of care (as provided in our st udy by Interactive Voice 
Response (IVR), additional provider involvement, an d education) improve 
medication adherence.  We hypothesize that the effe ct of the intervention on 
medication adherence will be mediated by the constr uct of health behavior, as 
measured by the Self-Efficacy for Appropriate Medic ation use Scale (SEAMS)  (75) 
and Stages Of Change (SOC)  (74) questionnaires.   
• Specific Aim 1:  We assess the association of the study intervention on health 
behavior by analyzing the change in results from the SEAMS (75) and SOC (74) that 
were administered at baseline and the one year follow up. 
• Hypothesis 1:  Subjects randomized to the intervention group have significantly 
improved change in health behavior as compared to the subjects randomized to 
the control group. 
• Specific Aim 2:  We assess how the association of the intervention on medication 
adherence is mediated by health behavior. 
• Hypothesis 2:  The association of the intervention on medication adherence is 
mediated by health behavior.  The constructs, self-efficacy and motivation, 





In order to examine the association of an intervention on health behavior, we are 
collecting data on a subset of the subjects from the study “Multi-Faceted Intervention to 
Improve Cardiac Medication Adherence And Secondary Prevention Measures - The 
Medication Study”  (47), a randomized control study.  This study assesses if the 
intervention that included the following core components: collaborative care (between 
pharmacists, primary care providers, and cardiologists), patient education (tailored to 
patient needs and provided on a regular ongoing basis), tailoring of medication regimens 
(i.e., simplification of dosing, use of pill boxes, synchronization of refill dates), and tele-
monitoring via IVR technology as well as patient-specific aides based on identified needs 
(47)  improve patients medication adherence rates.   
Patients are consented and then randomized 1:1 to either intervention or usual 
care. Approximately one week post discharge, the intervention patients meet with the 
study pharmacist in-person or if a patient is unable to make an in person visit, on the 
phone.  The pharmacist performs a medication reconciliation and answers any questions 
related to medications, emphasizing the importance of continuing to take medications as 
prescribed.  If questions arise about medications and/or if the indication for a medication 
is unclear based on the discharge instructions, the pharmacist contacts the patient’s 
PCP to resolve discrepancies. (47) 
Approximately one month post discharge the study pharmacist checks in with the 
patient to ensure comprehension of: 1) their medications, 2) the role of the study 
pharmacists to aid their adherence behavior, 3) the use of the phone messages, and 4) 
to answer any questions.  The intervention patients are then followed by the pharmacist 
for the study period of one year.  Intervention patients also receive two types of IVR 
calls: refill reminder calls and IVR educational calls.  The refill reminder calls occur when 
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patients’ cardio-protective medications are due to be refilled and last for one year while 
the educational calls are discontinued after six months.  Patients in both arms receive 
educational information; the intervention patients receive this information at the 
beginning of the study, whereas the usual care arm receives the educational information 
at their last visit.  This study was approved by the Colorado Multiple Institutional Review 
Board. (47) 
During the first and last study visit, patients complete the quantitative surveys of 
the health behavior components.  At the last study visit, the study personnel also collect 
a blood pressure measurement as well as verification of a lipid profile that has been 
completed within three months of the final visit. (47)   
Subjects 
This Aim includes a subset of 42 subjects from the “Multi-Faceted Intervention to 
Improve Cardiac Medication Adherence and Secondary Prevention Measures - The 
Medication Study” (47) study and are from the following sites: Durham NC, Seattle WA, 
and Denver CO.  The majority of the patients are from the Denver site (N = 33), Seattle 
(N = 5), and Durham (N = 4) only contributing a small percentage of the study subjects.  
The uneven distribution was due to the fact that Seattle and Durham had very few 
participants, 23 and 10 respectively.  Moreover, the decision to include these surveys 
occurred after the initial approval of the study, which missed obtaining baseline data for 
about 20 patients.   
Eligibility criteria include all patients admitted to the medical center with acute 
coronary syndrome (ACS) as the primary reason for hospital admission.  In addition, 
they need to use the VA for their usual source of care, or will commit to having their 
primary care in the future, and are at least 18 years of age.   
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During the first and last study visit, this subset cohort completes the quantitative 
surveys.  The Stages of Change for Medication Adherence (SOC) (74) and Self-efficacy 
for Appropriate Medication Use Scale (SEAMS) (75) are the two surveys used in this study 
to measure health behavior.   
Data 
Self-efficacy for Appropriate Medication use Scale (SEAMS) (75) – is a tool to 
evaluate self-efficacy, which is the confidence in one’s ability to perform a given task 
such as taking one’s medications.  This is an important determinant of medication 
adherence.   
Thirteen questions are evaluated using a 1-3 scale.  The total SEAMS (75) score is 
the final outcome.  The range is 13-39. 
Stages of Change for Medication Adherence (SOC) (74) – is a validated tool used 
to identify patients with potential adherence problems and to identify the stage that 
patients are at regarding their readiness/motivation to change their adherence behavior.   
The five stages are:  
1 = Pre-contemplation 
2 = Contemplation 
3 = Preparation 
4 = Action 
5 = Maintenance 
Covariates  
In order to characterize the study population, the following baseline 
demographics that include age, sex, race, body mass index (BMI), diabetes mellitus 
(DM), and history of coronary artery disease (CAD) are obtained to characterize the 
study population.  We will assess how balanced the 2 study arms are for each covariate 
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and will include any significantly unbalanced covariate in the analysis in order to obtain 
result estimates adjusted for the potential confounding of the unbalanced variables.  
Analysis 
• Specific Aim 1:  We assess the association of the study intervention with health 
behavior by analyzing results from the SEAMS (75) and SOC. (74)  The change 
from baseline is used as the outcome measure for both surveys in order to 
estimate the effect of the intervention on health behavior during the study period.  
The outcome measures are examined using descriptive statistics (means and 
medians, standard deviations and quartiles).  Unadjusted differences between treatment 
arms are estimated using t-tests. 
• Specific Aim 2:  We examine the extent to which health behavior mediates the 
effect of the intervention on medication adherence. 
The analyses utilize a Mediation Model that assesses if the intervention is a 
predictor of medication adherence and if so, to what degree the effect of the intervention 
is mediated by health behaviors.  The analysis first examines the effect of the 
intervention on medication adherence (c) (Figure 2), and then uses a mediation model to 
examine to what extent this relationship is mediated by health behaviors.    
  
      





Figure 2. Primary Outcome 
 
 
To assess c, we use a modified Refill Compliance (Recomp) method (47) to 









validated tool to measure adherence and designed for use with administrative pharmacy 
fill records.  Recomp is a single composite algorithm that incorporates information on 
both medication gaps and proportion of days covered. The modification for Recomp 
includes assessing new prescriptions in the same class and adjusting the PDC due to 
the overlap with the original prescription, adjusting for medications on hand from the 
prior 180 days, and removing inpatient days from the calculation to give patients credit 
for the medications not used.  Data on outside hospitalizations are unavailable and 
remains a limitation because we are unable to remove these inpatient days from the 
calculation that would give patients credit for the medications not used.  We are 
collecting this information but will not be able to include this in the analyses. 
Recomp first assesses improvement to the individual classes of medications, 
then averages the PDC of the four classes of cardiac medications.  It has been shown 
that improved clinical outcomes, such as control of hypertension, are a function of 
adherence to the regimen rather than to individual medications. (47) 
The first step in the mediation analysis (Figure 2) involves using a regression 
analysis Y = i1+cX + €1   to assess the effect of the intervention (the independent 
variable, X) on medication adherence (the outcome variable, Y). (90, 91)  Next, we use a 
regression model (a) M =  i2+ aX + €2   to assess the effect of the intervention on health 
behaviors (the potential mediator, M) (Figure 3).  Finally, the regression model (b) Y =  
i3+c’X + bM + €3 is used to estimate the effect of health behavior on medication 
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Figure 3. Secondary Outcome 
 
The mediated effect and its significance are estimated by the product a*b and its 
95% confidence interval.  This confidence interval is created finding the 95% asymmetric 
confidence limits using the PRODCLIN macro developed by MacKinnon, a more 
powerful method for creating the confidence interval for a product than the methods 
previously developed by both Baron and Kenny (1986) (90) and Sobel (1990). (91)  The 
degree to which the relationship between X and Y is mediated by M is found by 
comparing the direct effect of X on Y (found by c) to same effect in the presence of the 
mediator (found by c’ Y =  i3+c’X + bM + €3).  The proportion of the direct effect of the 
intervention (X) on medication adherence (Y) that is mediated by health behaviors (M) is 
reported in order to provide a quantifiable measure of the extent to which mediation is 
occurring. This difference, c – c’, is equivalent to the product a*b, the term tested to 
determine whether the observed degree of mediation is statistically significant.  
• Sub Aim 2.1: We examine the extent to which SOC mediates the effect of 
the intervention on medication adherence. 
• Sub Aim 2.2: We examine the extent to which SEAMS mediates the effect 















• Primary Outcome Measure 
The primary outcome measure for this Aim is medication adherence.  This 
outcome is ascertained in the study “Multi-Faceted Intervention to Improve Cardiac 
Medication Adherence and Secondary Prevention Measures - The Medication Study”  (47) 
a randomized control study.  We use the modified Refill Compliance (Recomp) method 
(47) to measure percent of days covered (PDC) by medications described above.   
• Secondary Outcome Measure 
The study utilizes two secondary outcome measures, SEAMS (75) and SOC (74) to 
assess the association of the intervention with health behavior.  They are also used to 
investigate whether or not they mediate the relationship between the intervention and 
medication adherence.   
Power and sample size estimates 
• Primary Outcome Measure 
The power and sample size estimates were calculated in the original randomized 
control study proposal.  They aimed to enroll 280 patients, and even with 10% lost to 
follow-up, they would still have 252 patients (126 patients in each group) at the end of 
study which is more than sufficient to assess the primary and secondary outcomes 
based on the sample size calculations. 
• Secondary Outcome Measure 
For our sample size calculation the estimated SD came from the pooled estimate 
of Dr. Kripanlani’s study, (76)  from the effect size of SEAMS scores, mean (SD) of 4.0 
(5.66), with a power of 90% with an alpha of 0.05.  The resulting sample size calculation 




Aim 3: Gather patients’ perspectives of how their e xperience with multifaceted 
interventions influenced their health behavior and its effect on their health 
outcomes after experiencing an ACS event 
Rationale 
In an effort to improve cardiovascular outcomes, multifaceted interventions 
targeting healthy behaviors and medication adherence in an ACS population have been 
employed.  To fully understand the effectiveness of these interventions it is important to 
obtain and assess the patients’ perspective of their experience.  In addition, the 
evaluation needs to understand what the patient perceives to be effective components of 
the multifaceted intervention, so that further implementation can focus on the successful 
components.  
The literature search found no studies that address the proposed question.  
Therefore, this research is needed to speak to this important gap in the literature. 
Objective 
What are patients’ perspectives of experiencing an ACS event and how 
does that affect their health behaviors?  
• Specific Aim 1: Use semi-structured qualitative interviews to gather patients’ 
perspectives of experiencing an ACS event and how that affects their health 
behaviors.   
What are patients’ perspectives of their relationsh ips with providers 
involved with their ACS care  and the impact on their health behaviors? 
• Specific Aim 2: Use semi-structured qualitative interviews to gather patients’ 




Do patients’ believe technology improves their heal th behavior and health 
outcomes? 
• Specific Aim 3: Use semi-structured qualitative interviews to gather their opinions 
and beliefs of whether or not technology improves their health behavior and 
health outcomes. 
Design and Subjects 
This Aim uses the same randomized control trial population as Aim 2.  Please 
refer to Aim 2 for the specific details of this population.  Sixty-four patients were 
interviewed.  The majority of the patients are from the Denver site (N = 51), Seattle (N = 
7), Little Rock (N = 3), and Durham (N = 3).  The uneven distribution is due to the fact 
that Seattle (N= 23) and Durham (N = 10) had very few participants.  Little Rock was not 
able to support the qualitative inquiry, although the Denver study coordinator did speak 
with three patients from Little Rock before we reached saturation. 
Data  
During the last study visit, patients are interviewed about their experience with 
the study to gather in-depth understanding of the phenomena of participation in a multi-
faceted intervention.  Due to issues such as illiteracy, cultural barriers, and prior 
experience with low response rates with surveys, qualitative interviews are used to 
investigate patients experience and their opinion of the effectiveness of a multifaceted 
intervention.  The data is collected in-person, using semi-structured, one on one, open-
ended interviews. We chose questions that address each component of the patients’ 
overall experience during the study and the effect of the study on the patients’ health 
behavior.  
The initial interview guide contains 14 semi-structured, open-ended questions for 
the intervention group and 10 for the usual care group.  The questions address general 
52 
 
items for both arms of the study such as: sharing their experience about having had an 
ACS event, associations they believe exist between their medications and their cardiac 
issues, and how their health has changed since their ACS event.  In addition, we ask 
about their relationships and communication with their providers when they are 
discussing their medication.  We also ask about barriers and facilitators regarding taking 
their medications and the effect of the study on their health behaviors.  The intervention 
group is asked specific questions about patient experience with the following: 1) their 
opinions about the reminder calls and the educational calls 2) working with the study 
pharmacists and the effects medication adherence and overall health; and 3) the effects 
of participation in the study on their health behavior.  Over time, the interview guide was 
adjusted to reflect the iterative process in the Grounded Theory analytic approach. 
Study staff conducts and audio-tapes the interviews, which range from 40 to 60 
minutes.  The audiotapes are transcribed verbatim.  This qualitative study was approved 
as part of the randomized controlled trial by the Colorado Multiple Institutional Review 
Board. (47)  
Baseline demographics that include age, sex, race, BMI, DM, and history of CAD 
are obtained to characterize the study population.  
Analysis 
• Specific Aim 1: Use an iterative, inductive and deductive toolkit of analytical 
strategies, drawing primarily on grounded theory, and consultative and reflexive 
analysis to assess the participants’ perspective of experiencing an ACS event. 
• Specific Aim 2: Use an iterative, inductive and deductive toolkit of analytical 
strategies, drawing primarily on grounded theory, and consultative and reflexive 




• Specific Aim 3: Use an iterative, inductive and deductive toolkit of analytical 
strategies, drawing primarily on qualitative content analysis, and consultative and 
reflexive analysis to analyze their opinions and beliefs if technology improves 
their health behavior and health outcomes. 
All transcripts are analyzed by members of the study team using grounded theory 
and content analysis methods. (68-70, 72-74)  In order to emphasize respondent perspectives 
and de-emphasize researchers assumptions, the analysis begins with repeated readings 
to achieve immersion (71) followed by initial open coding using an emergent rather than 
an a priori approach. (86)  Words, sentences, and paragraphs are treated as coding units 
or “meaning units”.(87)  In compliance with a constructivist grounded theory approach, we 
used a constant comparative method of going in and out of the data, as new interviews 
were completed, analyzed, and compared to previous data.  As patterns, relationships, 
themes, and theory emerged and were analyzed, we advanced the investigation with 
thematic and theoretical sampling.  This means that the questionnaire was changed to 
reflect the further inquiry into the specific information (themes and or theory) that was 
emerging from the data.  This allows the researchers to confirm, refute, or expand the 
findings. (71)   
Subsequent analysis uses a deductive approach to capture the essence of the 
impact of the multifaceted intervention.  The analysis involves a content analysis to 
assess the classification and quantification of patients’ beliefs in the validity of the 
components of the multifaceted intervention. (68, 86-87)   
The preliminary results are reviewed by members of the thesis committee, to 
assess their evocativeness, thoroughness, and comprehensiveness. (88)  For analytical 
rigor, we have organized the analytical process with in-depth training of interviewers and 
analysts.  A code book is produced that is compiled with emergent and a prior stable 
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codes.  To establish coding reliability we assess an inter-coder reliability as is a measure 
of agreement.  To add to the analytical rigor, we provide an audit trail that documents all 
analytic procedures and decisions.   Finally, we triangulate the results from the 
qualitative findings, observations, and the quantitative findings. 
Outcome Measures 
An analytic summary of the interviews is written. The emergent categories and 
theories are documented and presented in the resulting thesis.  Patients' own words and 
narratives are used to preserve the tone and emotion of their experiences and increase 
the theoretical depth of the final description.  
 
Integration of Aims 
An integration of the two forms of data, quantitative and the qualitative, are 
combined for the strengths of both to answer the research question. (54) A merging data 
approach is used to integrate the quantitative and qualitative data.  This approach is 
achieved by reporting the two types of data together and is presented in the final 
analysis section of the thesis.  The quantitative data are presented with the qualitative 
quotes that either support or refute the quantitative results. (54) 
 
 
“Not everything that can be counted counts and  








Aim 1 Gather an in-depth understanding of the pheno mena of participation in a 
pharmacist lead, multi-faceted intervention of hype rtensive patients using an 
Interactive Voice Response System and Home Blood Pr essure Monitor 
Results 
Participants Baseline characteristics were comparable between the two groups, 
except that usual care patients were more likely to have diabetes or chronic kidney 
disease (74% vs. 58%; p = 0.045) (Table 2).  Most of the study participants were male 
(81.5%), and the overall racial makeup was 52% non-Hispanic White, 23% Hispanic, 
19% African American, and 4% Native American.  The majority of the study subjects 
were 50 years and older (87%).  Four of the 32 intervention patients interviewed at 
Denver Health and three of the 46 intervention patients interviewed at the VA had not 
used the IVR system, yet we have included their interviews in the analysis. (25) 
Experiences Participants reported a range of intervention effects, from no effect 
to significant effect upon their health behavior and control of their hypertension.  A 
majority (75%) of study participants indicated that they experienced a positive effect from 
the study, such as building a relationship with the medical personnel, feeling empowered 
to engage in bi-directional conversation with their healthcare provider or increased 
participation in their healthcare, improving their health behavior, and increasing their 
healthcare knowledge.  Eighty-six percent of the intervention and 62% of the usual care 
patients indicated that they experienced a positive effect.  Eighty-two percent of women 
compared to seventy-three percent of men, found the study to have a positive effect.  
More African American (89%) participants than Hispanic (71%) and non-Hispanic White 
(74%) participants indicated a positive effect.  No difference was found in the percent of 
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patients experiencing a positive effect between the two study sites, a notable result 
given the difference in study populations and healthcare systems.  Predominately older 
men are enrolled in the Veterans Affairs Health Care System, while Denver Health is a 
local safety net hospital that cares for many of the indigent population of Denver, 
Colorado. (25)   
 
Table 2. Aim 1 Demographics 
Demographics  Intervention  
N = 78 
Usual Care  
N = 68 
Gender    
Male 64 (82) 55 (81) 
Female 14 (18) 13 (19) 
 








White 41 (53)  35 (51) 




Hispanic 18 (23) 23 (34) 




DMCKD 45 (58) 50 (74) 
CAD 14 (18) 11 (16) 
Prior MI 11 (14) 8 (12) 
Prior PCI 5 (6) 7 (10) 
Prior CABG 4 (5) 1 (0.02) 
Hyperlipidemia 54 (69) 50 (74) 
Stroke History 12 (15) 8 (12) 
   
Data are expressed as n and percent (%) or mean ± SD unless otherwise noted 
 
Of the 37 study participants who did not report a positive experience, most (70%) 
were usual care patients who shared that the study had no effect on their blood 
pressure.  The remaining 11 (30%) who did not report a positive experience were 
intervention patients who had not worked with the study pharmacist.  Two patients had 
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negative comments about the study.  One subject, who never used the IVR system, did 
not like being contacted when he did not report his BP measurements.  Another patient 
was fearful the pharmacist would replace his PCP and the study would “get his doctor in 
trouble because my blood pressure’s been up.”  However, he indicated improving his 
medication adherence had resulted in a positive effect, “… it proved it right there in my 
readings this morning. It’s working”.  Some patients mentioned personal issues that the 
intervention was unable to address such as financial problems, pharmacy rules, and 
transportation issues that could be barriers in their ability to improve their medication 
adherence.  When asked “What makes it difficult to take your medicines?”   two patients 
responded with, “If the water was shut off.”  and “Just when I can’t afford them.” (25)   
Of those who had positive experiences, the data suggests six main themes 
related to the successful reduction of blood pressure.  The themes are: 1) Improved 
relationships with medical personnel; 2) Increased knowledge of hypertension; 3) 
Increased participation in their healthcare and personal empowerment; 4) Greater 
understanding of the impact of health behavior on BP; 5) High satisfaction with 
technology, including the BP cuffs and the IVR system; and 6) The effects of the study 
on the patients’ healthcare utilization.  Each is discussed in further detail.  (25)   
Improved Relationships with Medical Personnel Thirty-two percent of the 
intervention patients indicated that the multi-faceted intervention created relationships 
that made them feel cared about and encouraged them to become more active in their 
healthcare.  Some patients spent more time than others with the study personnel 
because they contacted the pharmacists with questions or their home BPs warranted the 
study pharmacist intervention.  Many of these patients attributed improved medication 
adherence and BP reduction to their positive relationships with the pharmacist.  They felt 
that this positive relationship was unusual in routine clinical practice.  In the words of one 
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participant who was initially frustrated with the technology but was very appreciative of 
the support and concern that he received from the study personnel, “Oh, it was great, 
you got me spoiled there for a minute it was like somebody really cared for…my high 
blood pressure …”(25)   
Increased Knowledge of Hypertension Though all study patients enrolled in the 
intervention had uncontrolled hypertension, most had limited knowledge about its causes 
and/or consequences, as well as comprehension of the therapies utilized to treat it.  The 
relationships that developed between some of the patients and the study personnel 
supported a level of comfort and trust, which allowed give-and-take in the educational 
process regarding BP.  Seventy-eight percent of the intervention group indicated that 
their overall awareness of blood pressure increased, including the definition of systolic 
and diastolic numbers, the ramifications of too much salt and lack of exercise, and the 
overall importance of blood pressure on their health status.  As one participant put it,  
…..when they take my blood pressure I didn’t know what the numbers meant at 
all and now I know what they mean so that’s helped me a lot because you know 
they check my blood pressure, ok, I don’t know if it’s normal. It’s high, it’s low, so 
I started asking question and now I know what it means so that helped me a lot. 
 
More African American participants (85%) in the study said that their knowledge of blood 
pressure increased from participation in the study, compared to 68% of both Hispanic 
and non-Hispanic White counterparts.  Interestingly, 60% of participants in the usual 
care group also indicated that being in the study increased their knowledge of blood 
pressure.  Comments from some in the group suggest that the personal interaction and 
the educational information they received gave them the impetus to lose weight, 
exercise, and to adhere to their prescribed medications.  (25)   
Increased Participation in their Healthcare and Personal Empowerment Almost 
half of the participants (47%) from the intervention arm said that they became active 
participants in their healthcare by exercising more, eating healthier foods, and sharing 
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their home BP measurements with their primary care providers (PCPs).  In addition, 27% 
of the intervention patients expressed that the knowledge and experience they obtained 
from the study empowered them to increase their interactions and communications with 
their PCPs.  The knowledge and information (i.e., home BP measurements) they brought 
to the PCP visit facilitated a bi-directional conversation that supported their self-care as 
well as assisted their clinicians in the management of their hypertension.  As one patient 
said, “So, it’s made me have a two way street with my PCP.”  Interestingly, patients from 
both study arms reported more confidence in their ability to change their beliefs and 
behaviors.  A minority (10%) of usual care patients also indicated that the added 
knowledge and understanding of the dynamics of hypertension increased their 
confidence about the disease, which lead to better communication with their PCPs.  In 
the words of one such usual care patient,  
Well, after reading the book that you gave me, I realized that things weren’t 
looking, … good for me ‘cause I have an aneurysm in my brain that is inoperable 
and I realized after reading that I could blow my head off and I started going to 
my doctor every two weeks to get the blood pressure under control, and I started 
losing weight, going on a diet.  I started walking, I started eating healthier and 
I’ve lost quite a few pounds. (25)   
 
Among the intervention group, 59% of African Americans, 37.5% of Hispanics, 
and 44% of non-Hispanic Whites shared that they increased their participation in their 
healthcare.  Regarding their feelings of empowerment, 29% of non-Hispanic Whites 
reported that they were more empowered to interact with their healthcare providers as a 
result of the study, 25% of Hispanics and 24% of African Americans reported that they 
felt more empowered to interact with their PCP as a result of the study.  Comparison of 
the two sites indicates that 24% of the patients from the VA and only 12% of Denver 
Health patients became empowered to interact more with their PCP as a result of the 
study.  (25)   
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Six participants shared that fear was either a motivator or an inhibitor of 
participation in their healthcare.  These patients were fearful of learning that they had a 
serious problem, afraid to learn how high their BP was, afraid of their physician, and/or 
fearful of losing their job if they took excessive time off to go to the doctor.  One man 
explained how Colorado is a no fault state and that he could be fired for missing work 
because of his surgeries.  Another explained that he was afraid of his doctor and 
therefore, “I do exactly what she says.”  For such participants, the support and tools (e.g. 
education about BP management and observing the consequences of appropriate health 
behavior from home BP measurement) provided by the study were helpful in addressing 
and thus partially alleviating some fears.  (25)   
Greater Understanding of the Impact of Health Behavior on BP Some of the 
patients (36%) were able to translate their behaviors such as eating too much salt, or 
medication non-adherence to the home blood pressure readings.  A few subjects said 
specific issues such as forgetting to take their blood pressure measurements and/or 
difficulty finding time to perform the measurement impeded their ability to comply with 
study requirements.  As one participant said,  
 think taking my BP regularly really made me show that I did need to take the 
medication and that was somewhat motivating, … even though I didn’t cheat or 
fudge on it, on taking the medication … I often thought … I don’t think this might 
be doing anything…so it did show that the medication was important. (25)   
 
Fifty-nine percent of African Americans in the intervention group indicated that 
they were able to transform the information they received into improved understanding of 
their health behavior, while only 37.5% of Hispanics and 24% of non-Hispanic Whites did 
so.  (25)   
Satisfaction with IVR Technology and Home BP Monitoring The technology 
utilized in the study consisted of an electronic blood pressure cuff and an IVR telephone 
system.  Overwhelmingly (94%), the patients reported having no difficulties taking their 
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blood pressure at home. In fact, a couple of the patients said that they “enjoyed” taking 
their blood pressures at home.  Similarly, a significant majority of patients (90%) found 
the IVR system to be user-friendly and supported their efforts to lower their blood 
pressure and address other issues such as talking with a nurse, or contacting smoking 
quit lines and exercise programs.  Participants particularly noted the ease of contacting 
the study pharmacist, refilling their prescriptions, and appreciated the reminder calls.  As 
one participant said, “the fact is if they [the IVR] hadn’t called a lot of times I probably 
wouldn’t have done as well as I did.” (25)   
Despite the overall satisfaction with the technology, some patients became 
frustrated when the system was unavailable and they were unable to report their BP 
results.  A few subjects reported other issues with the system, such as having difficulty 
pushing the buttons on their cell phones and the system was initially cumbersome.  One 
participant indicated that the phone system wasn’t an issue for the first few months but 
after a while it became tiresome.  He suggested a website may be easier and more 
convenient for some.  Two patients were concerned about the cost when using their cell 
phones.  Ultimately, most patients said the system was successful in supporting them to 
attain their blood pressure goals.  A couple of the patients even enjoyed something akin 
to a “relationship” with the IVR system that supported their goal of reducing their blood 
pressure levels.  “She [the IVR] would say you reached your goal congratulations, and I 
was elated to hear that so I worked that much harder the next time so I could hear those 
words again.”  (25)   
Healthcare Utilization Overall, the intervention had mixed effects on healthcare 
utilization outside the study.  Some participants reported that the intervention controlled 
their hypertension with appropriate medication adjustments and this resulted in less 
urgent care visits.  Others realized they needed to be more concerned about their 
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hypertension and consequently increased their visits with their PCP.  Healthcare 
utilization was not a major issue for most of the study participants.  Only 15% of the 
intervention participants and 10% of the usual care patients said the study had any effect 
on their healthcare utilization.  (25)   
When considering the generalizability of this intervention, a couple of patients 
shared their opinions of the potential positive effects of this type of program on the 
medical system and specific populations such as the Latino community. (25)  “Great 
program.  Should expand it because … the Latin community, we just naturally eat bad 
and could use more help like this.”   
I really do think it’s a good program.   Really, I think it could make a huge 
difference in problems with compliance.  I think that kind of personalization would 
really help.  And it would take a lot of pressure off the medical system itself. (25)   
 
The Association Between Program Impact and BP Control An additional analysis 
assessed the association between patients’ report of a positive impact of the program 
and achieving blood pressure goals.  In the intervention group, most of the patients 
(86%) shared that the study had a positive effect and of those patients, the majority 
(68%) reached their systolic goal.  Among intervention patients who reached their 
systolic blood pressure goal, most (89%) felt the study had a positive effect.  In the usual 
care group, 62% indicated they experienced a positive effect from participating in the 
study and of these participants 55% reached their systolic BP goal.  Overall, 50% of the 
usual care patients reached their systolic goal.  As one might expect, it appears that 
those participants who had a positive experience with the program also had a positive 
impact on their blood pressures.  As one participant said 
…you’re going to save a lot of lives and it’s going to prevent a lot of strokes and 
heart attacks ‘cause … they don’t seem to realize and neither did I until I got 
more education about blood pressure … how important this is to monitor your 
blood pressure ….and … I think it’s going to help diabetes people … I’ve noticed 




Aim 2: Assess the association of technology facilit ated interventions on 
medication adherence mediated by health behaviors 
Results 
Participants  Forty-two patients are in the analysis.  The randomization resulted 
in 20 patients assigned to the intervention group and 22 in the control group.  Baseline 
demographics including age, sex, race, BMI, DM, and CAD history were obtained to 
characterize the study population and were found to be comparable between the two 
groups (Table 3).  All but one of the participants were male (98%), and the overall racial 
makeup was 79% White, 14% African American, 5% Hispanic, and 2% Native American.  
The mean age of the population was 65 years (SD 9.0). 
Due to the number of patients at the sites who were not administered the 
surveys; we assessed their baseline characteristics to determine if there were any 
significant differences between the two groups.  No significant differences between the 
patients who received the surveys compared to those who did not were found (Table 4). 
Primary Outcome The medication adherence intervention significantly improved 
patients’ adherence to their cardiac medications compared to the control group. The 
mean Recomp score for the intervention group is 0.80 (SD 0.12, 95% CI (0.75, 0.86)).  
The control group’s mean Recomp score is 0.67 (SD 0.16, 95% CI (0.60, 0.74)).  The 
difference is 0.133, 95% CI (0.043, 0.222) p =0.0045 and is defined in the mediation 





Table 3. Aim 2 Demographics and Covariates 
 
Demographics  Intervention  
N = 20 
Usual Care  
N = 22 
 
P Value 
Gender    1.00 
Male 20 (100) 21 (95.5)  
Female 0 (0) 1 (4.5)  
 









   
0.06 
White 13 (65)  20 (91)  
Non-White 7 (35) 2 (9)  
Co-morbidities     
Mean BMI (SD) 32.9 (8.4) 31.2 (6.8) 0.48 
DM 8 (40) 7 (32) 0.75 
CAD 11 (58) 15 (68) 0.53 
Results are expressed as n (%) or mean (SD)  
 
Table 4. Aim 2 Demographics and Covariates of those  who were administered the 
survey vs those who were not administered the surve ys 
 
Demographics  Surveys  
N = 42 
No Surveys  
N = 66 
 
P Value 
Gender    1.00 
Male 41 (97.6) 63 (95.5)  
Female 1(2.4) 3 (4.5)  
 









   
0.31 
White 33 (78.6) 46 (69.7)  
Non-White 9 (21.4) 20 (30.3)  
Co-morbidities     
Mean BMI (SD) 32.0 (7.5) 30.8(6.4) 0.40 
DM 15 (35.7) 28 (42.4) 0.49 
CAD 26 (61.9) 37 (56.1) 0.55 
Results are expressed as n (%) or mean (SD)  
 
 
• Specific Aim 2.1:  The self-efficacy (SEAMS survey) mean baseline score is 
31.95 (SD 6.72) 95% CI (29.86, 34.05).  For the intervention group the mean baseline 
score is 33.45 (SD 5.32, 95% CI (30.96, 35.94)) and the usual care group is 30.59 (SD 
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7.64 95% CI (27.20, 33.98)).  There is no significant difference between the two groups 
(p = 0.17) (Table 5).    
The SEAMS mean 12 month score is 34.55 (SD 4.47) 95% CI (33.16, 35.94).  
For the intervention group the mean 12 month score is 35.25 (SD 4.54, 95% CI (33.12, 
37.38)) and the usual care group is 33.91 (SD 4.41, 95% CI (31.96, 35.86)).  There is no 
significant difference between the two groups (p = 0.34) (Table 5).   
 







N = 20 
Usual Care  





















Baseline 31.95 (6.72) 33.45 (5.32) 30.59 (7.64) 0.17 
12 Months 34.55 (4.47) 35.25 (4.54) 33.91 (4.41) 0.34 
Difference (a)  1.8 (3.8) 3.3 (7.8) 0.42 
     
Mean SOC 
SURVEY (SD) 
    
Baseline 4.62 (0.88) 4.80 (0.62) 4.46 (1.06) 0.20 
12 Months 4.83 (0.76) 4.85 (0.67) 4.82 (0.85) 0.9 
Difference (a)  0.05 (0.94) 0.36 (0.73) 0.23 








    
<.0001 
Results are expressed as n (%) or mean (SD) 
 
The mean change (SD) from baseline to the end of the study period for the 
SEAMS survey was 2.6 (6.0).  No significant difference was found in the change of the 
self-efficacy (SEAMS survey) in taking medications between the control group compared 
to the intervention group.  The mean difference score from baseline to one year in the 
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control group is 3.32 (SD 7.83) compared to the intervention group 1.80 (SD 3.79) with 
the difference of -1.52 95% CI (-5.42, 2.38) p = 0.44 indicating there is no difference 
between the two groups (Table 5).  This path is denoted by (a) in the mediation model. 
The SOC mean baseline score is 4.62 (SD 0.88, 95% CI (4.34, 4.89)).  For the 
intervention group the mean baseline score is 4.8 (SD 0.62, 95% CI (4.51, 5.09)) and the 
usual care is 4.46 (SD 1.06, 95% CI (3.99, 4.92)).  There is no significant difference 
between the two groups (p = 0.20) (Table 5).   
The SOC mean 12 month score is 4.83 (SD 0.76, 95% CI (4.60, 5.07)).  For the 
intervention group the mean 12 month score is 4.85 (SD 0.67, 95% CI (4.54, 5.16)) and 
the usual care is 4.82 (SD 0.85, 95% CI (4.44, 5.20).  There is no significant difference 
between the two groups (p = 0.9) (Table 5).   
 Similar results are found in the SOC survey as was found in the SEAMS survey 
that assesses the motivation to change adherence behaviors.  The mean difference 
score from baseline to one year in the control group is 0.36 (SD 0.73) compared to the 
intervention group 0.05 (SD 0.94) with the difference of -0.31 95% (-0.84, 0.21) There is 
no significant difference between the two groups (p = 0.23).  This path is denoted by (a) 
in the mediation model. 
Therefore, no significant association exists between the medication adherence 
intervention and health behaviors, self-efficacy (SEAMS survey) or motivation (SOC 
survey).   
Based on the findings of a small change occurring from baseline to the 12 month 
follow up for both surveys, an additional analysis was investigated.  We looked to see if 
there was an association between the baseline SEAMS and SOC surveys and the 
dependent variable of medication adherence.  The mean of the SEAMS baseline data is 
31.95 (SD 6.72).  A significant association exists with patients’ baseline self-efficacy and 
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the medication adherence at 12 months (p = 0.0012).  We also risk adjusted using all the 
covariates and the no significant adjustments were observed.  The mean of the SOC 
baseline data is 4.62 (SD 0.88).  A significant association was found between the 
baseline stage of change scores and the patients’ medication adherence at 12 months 
(p <.0001).  Therefore, health behaviors constructs, self-efficacy and motivation, are 
important constructs for prediction of medication adherence.  Evaluation of self-efficacy 
and motivation should be determined to assess the patients’ ability to adhere to 
recommended medical treatment and if needed, interventions aimed to improve patients’ 
self-efficacy and motivation, should be initiated to support patients’ adherence to their 
prescribed therapies. 
• Specific Aim 2.2:  No significant association exists between the medication 
adherence intervention and the change from baseline to 12 month time frame for the 
health behaviors, self-efficacy (SEAMS survey) or motivation (SOC survey). Therefore, 
based on the mediation model, these health behavior constructs do not seem to mediate 
the relationship between the medication adherence intervention and the outcome of 
medication adherence.  Yet, this is an educational process and therefore, we continued 
the analysis for the experience. 
The mediation model uses the coefficients of the individual analyses (paths) to 
compute the mediation analysis; therefore the coefficients will be identified in the 
following discussion. 
The mediation model assesses the extent to which a variable (health behavior) 
mediates the effect of the independent variable (intervention) on a dependent variable 
(medication adherence).  The association between the intervention and health behaviors 
is described above and denoted by (a).   
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The second step in the medication model is to determine the extent to which the 
variable (change in health behavior) is associated with the dependent variable 
(medication adherence) while controlling for the independent variable (intervention) and 
denoted by (b).  A significant association was found in both health behavior constructs.  
The effect of self-efficacy (SEAMS survey) on medication adherence while controlling for 
the intervention, this path is denoted as (b) was -0.009 (SE 0.003) p= 0.01 and the effect 
of motivation (SOC survey) was -0.060 (SE 0.025) p = 0.017.   
The same models are used to assess the association of the intervention on 
medication adherence while controlling for health behavior, denoted as (c’).  There was 
a significant association for both analyses.  The SEAMS survey estimate was 0.119 (SE 
0.041) p= 0.006 and the estimate of motivation (SOC survey) was 0.113 (SE 0.042) p = 
0.011.   
The estimate of the effect of the intervention on medication adherence that is 
mediated by self-efficacy (SEAMS survey) is therefore -1.518 * -0.009 = 0.014 (95% CI 
 -0.022, 0.058) which accounts for 12.4% of the total effect.  Self-efficacy is not a 
statistically significant mediator (α = 0.05) of the effect of the intervention on medication 
adherence, as evidenced by the 95% confidence interval containing 0.  Similarly, the 
effect of the intervention on medication adherence that is mediated by stage of change 
(SOC survey) is -0.314 * -0.064 = 0.020 (95% CI -0.010, 0.059) which accounts for 
17.7% of the total effect.  The same conclusion is reached that stage of change does not 





Aim 3: Gather patients’ perspectives of how their e xperience with multifaceted 
interventions influenced their health behavior and its effect on their health 
outcomes after experiencing an ACS event 
Results 
Participants Sixty-four patients were interviewed.  Majority of the patients were 
from the Denver site (N = 51), Seattle (N = 7), Little Rock (N = 3), and Durham (N = 3).  
The uneven distribution was due to the fact that Seattle and Durham had very few 
participants.  Little Rock was not able to support the qualitative inquiry; therefore, the 
Denver team contacted the three subjects included in this inquiry.  The randomization 
resulted in 33 patients assigned to the intervention group and 31 in the control group.  
Baseline demographics included age, sex, race, BMI, DM, and CAD History were 
obtained to characterize the study population and were found to be comparable between 
the two groups (Table 6).  Most participants were male (97%), and the overall racial 
makeup was 75% White, 11% African American, 8% Hispanic, 2% Pacific Islander, 
Asian 1%, and 3% Native American.  The majority of the study participants were 50 
years and older (95%) with a mean age of 66.5 years. 
Experiences The intent of this research was to explore the experience of having 
an ACS event and how this event affected patients’ lives, health, and health behaviors. 
In addition, we inquired about patients’ relationships with their health care providers and 
attempted to delve into the meaning of bi-directional conversations.  Due to the use of a 
grounded theory approach that resulted in thematic and theoretical sampling, multiple 
iterations of the interview guide evolved so that not everyone was asked the same 
questions; which may affect an exact reporting of the proportion of respondents.  A 
strong attempt was made to discern the true denominator.  In addition, patients gave 
opinions and insights that were not specifically asked for in the interview guide, such as 
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their opinion of the care they received at the VA, therefore, these values are not exact.  
Yet, this is not of concern for the authors; because qualitative analysis use of numbers is 
for descriptive context only. 
 
Table 6. Aim 3 Demographics 
 
Demographics  Intervention  
N = 33 
Usual Care  
N = 31 
Gender    
Male 32 (96.97) 30 (96.77) 
Female 1 (3.03) 1 (3.23) 
 








White 24 (73)  24 (77) 
Non-White 9 (27) 7 (23) 
   
Co-morbidities    
Mean BMI (SD) 32.0 (7.4) 32.0 (7.1) 
DM 14 (42) 10 (32) 
CAD 20 (63) 18 (58) 
Data are expressed as n and percent (%) or mean ± SD unless otherwise noted 
 
 
Experiencing an ACS event was a profound, life changing, event for most (67%) 
patients in the Medication Study.  Some (23%) said there was no change or that they 
just accepted the event and moved on.  The remaining 10% did not address the 
question. The consequences of the ACS event were determined by how patients 
perceived the experience. 
Consequences of the ACS events were varied.  Several patients (36%) stated 
their life changed because of physical limitations, which consequently affected specific 
aspects of their lives.  A few (N = 3) men indicated a loss in their self-identity, while 
others said their family roles changed based on their level of physical ability, and 
relationships with significant others were also affected.  Two patients felt less worthy and 
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now were unsure of who they were, and what contribution they could make to the family 
and society.  Some patients (34%) described being fearful, concerned, devastated, and 
depressed.  They acknowledged being physically and mentally challenged, and some 
shared that they were now physically restricted and regretful of their limitations.  In 
addition, a few patients (8%) became fearful of overly exerting themselves, which may 
cause another attack.  .A few of these patients described realizing their mortality and 
their fear of dying.  These factors resulted in either motivating or hindering their ability to 
effectively change their health behaviors.  A couple of gentlemen were surprised and 
disappointed to have had a heart attack despite their previous positive health behaviors. 
Therefore, these patients needed to redefine how to live their lives and reassess their 
priorities.  
On the other hand, six patients indicated that having the ACS event caused them 
to become reflective and were thankful to have survived.  Some patients believed that 
going forward they needed to take care of themselves for their families, as well as for 
themselves.  Eight patients shared that they physically felt better after their attack, and 
the improvement motivated them to effectively change their health behavior.  
Consequently, these patients and others (34%) became motivated to be active 
participants in their health care, such as changing their lifestyle to become healthier, 
being aware of good nutritional habits, and adhering to the prescribed medication 
regimens.  Thus, these patients were able to move forward and address the needed 
change in their health behaviors. 
In addition to how this event affected patients’ lives, health, and health behaviors, 
we inquired about patients’ relationships with their health care providers.  Overall, many 
patients (48%) shared that they were grateful for the quality care they received at the VA 
and that they had good communication with their providers and had no problems talking 
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openly and honestly with their doctors (84%).  Patients shared that providers who were 
“regular” people were comfortable to talk with and to even express disagreement.  
Patients who were comfortable with their providers described them as patient, 
understanding, and took the time to discuss the details and reasons for each of the 
patient’s medications. These patients expressed the importance of the good 
communication with their providers, including the ability to be “heard,” and to discuss 
their care, especially their medications.  Good communication between patients and 
providers involves having both parties be comfortable being truly honest and open. 
The honest and open conversation between patients and providers is defined as 
a bi-directional conversation.  This occurs when the perspectives of both the provider 
and the patient are accounted for in the conversation and where patients are truly 
comfortable disagreeing with the providers’ recommendations and the provider is open 
to hear the patients’ perspective.  In our study those who experienced bi-directional 
conversations (67%),.suggested it supported their quality of care.  Patients realized that 
high-quality care requires both the provider and the patient to be active participants in 
this relationship.  As one gentleman said, “I don’t think they know the whole story about 
the individual.  They are a lot smarter than I am on everything, but sometimes, there’s 
things they don’t take into consideration.”  Others added that it was their responsibility to 
tell the provider “everything” and to help the providers remember specific details about 
themselves because the providers were busy and had limited time with each patient.  
Another patient shared, “You know in the long run, people can prescribe medication but 
it is up to me to decide if I will take it or not, and I take it by the way.”  The patients 
enjoyed these respectful and equivalent relationships.   
However, everyone did not share the same experience.  Some patients (16%) 
did not share that the communication with their providers was good and one patient 
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stated that “doctors are not gurus; they are just people like me”.  Some patients were 
just not comfortable discussing differing opinions and being honest with their providers.  
Six people specifically said they would not tell their provider if they disagreed with the 
prescribed treatment.  Finally, a couple of patients shared that their providers were not 
open to hear patients’ opinions.  One patient who was not “forthcoming” about his non-
adherence said he was conflicted about the side effects of his medications but not 
comfortable discussing this with his provider.  The lack of open communication 
prevented the patient from obtaining the best care from his clinician because the 
physician lacked the appropriate information to determine the best treatment plan. 
This discussion regarding the lack of communication with providers regarding 
medications exposed an underlying issue of medication adherence.  Many people (48%) 
shared dislike for taking medications and a few wanted to get off of them as soon as 
possible.  This was true even though they believed that they would be on them 
indefinitely.  However, the real question is how many of these people share their honest 
opinions and feelings with their providers and more importantly, how many share their 
honest adherence behavior?  Yet, the most common barriers to medication adherence 
identified were forgetfulness and being out of their routine (41%).  .   
Lastly, we explored patients’ experiences with the Medication Study, specifically; 
we addressed their perspectives of being in the study, working with the pharmacists, and 
receiving the IVR messages.  Content analysis revealed that most patients in the 
intervention arm (67%) had a positive experience in the study.  The positive experience 
was directly correlated with patients’ interaction with the study pharmacist, as one 
caretaker said,  
….before the study I did not know who to call at the VA to get clarification. But 
knowing that the pharmacist is a phone call away and that is a person I can ask 
about his medications it has helped me a great deal keep the medications 
organized and the pill box up to date and correct.  
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The IVR messages, including both educational messages and cardiac 
medication refill reminder calls, received mixed reviews.  Overall, 67% of the group 
randomized to the intervention group reported receiving the messages and 33% 
indicated they did not receive or did not remember receiving the calls.  Yet, only 42% of 
participants in the intervention group shared they believed the messages had a positive 
effect on their adherence behavior.  One patient said that overall, the messages made 
him feel cared about and the refill messages were helpful.  A couple of patients shared 
insights about the refill messages, with one saying that it would have been helpful to 
know which medication needed to be refilled, because the messages were generic only 
indicating that their prescriptions needed to be refilled.  Other patients shared that the 
repeated messages were annoying because they would continue after the medications 
had been filled.   
 Of those who had shared their perspectives about medication adherence, the 
data suggests five main themes related to the support medication adherence: 1) Bi-
directional conversations; 2) Support of others; 3) Fear; 4) Positive attitudes; and 5) 
Establishing a routine utilizing a pill box.  Each is discussed in further detail.   
Bi-directional conversations/relationships: Patients indicated the importance of 
communication between patients and providers. Sixty-seven percent of all patients 
identified having bi-directional conversations between themselves and providers, which 
appears to be a key element of medication adherence.  
They’ve always communicated to me that the absolute importance of it, without 
being nasty. You know, it’s not like a Daddy/Mommy relationship and you are the 
child. It’s always on an adult level. You know nobody’s pointing a gun at me 
saying you gotta’ take your pill. 
 
Patients who are comfortable being honest with their providers are active participants in 
the shared decision-making process that is essential for adherence.  As one patient said, 
“….how [would he] know what was best for me if I can’t tell him how I feel about it.”  Of 
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those who do not share their opinions and felt they were not listened to, one said, “…but 
I just don’t want to argue with him to tell him, he’s not in my body. And I know what I feel 
and he can’t tell me what I feel.”  
Some patients shared that basic communication was lacking and it caused 
concern.  If patients do not understand how medications work, their adherence is 
affected, as one patient said, “Well they keep telling me that everything is fine, [if] 
everything is fine, then I don’t see the reason why I can’t get off of them [medications].”   
Providers must be open to hear the honest perspective of the patient without 
judgment.  Furthermore, providers have to take the time to be sure the patient 
understands the evidence based recommendations and also work with the patient 
toward a mutually agreed upon treatment plan.  When asked if he felt comfortable telling 
a provider that he didn’t agree with him a patient said, “Oh yea I do…but they don’t .  
Well you know it’s my body, and I have to live in it, they don’t. And still another shared: 
and he’s acting like I got no business being there, there’s nothing wrong with 
me, telling me we just did an arteriogram several months ago and there wasn’t 
any problem and stuff like that and that just kinda ticked me off!  Nobody knows 
my body like I know my body! And he finally agreed to do another arteriogram 
and that’s when they found out that one graft was 100% blocked! 
 
And still another said, “I found for myself because I didn’t ask the questions or 
perhaps the doctor didn’t fill me in enough on the medication itself or the 
pharmacist…. the doctors don’t think that we’re capable of understanding 
sometimes.”   
 
Support of others Patients (22%) shared that having other people to remind 
them, help organize their medications, and overall encouragement was helpful.   
A patient shared, “…well the people that know I am taking the medicine, that’s the first 
thing… did you bring your medicine? …. They, they’re making sure that, you know, I am 




Fear Fear was described as a double edged sword.  Fear of having another 
cardiac event or dying (8%) motivated people to follow prescribed behaviors such as 
adhering to the medication regimen, eating healthy, and exercising.  As one patient 
shared,  
She goes I’m going to be honest with you, you won’t survive the next one.  So 
that changed things, whoah, and then my two grandkids, they are only four and 
three. That’s another thing…yea…keeps making sure I’m going to take my 
medicines…..  
 
Yet, it also caused five people to not exercise in fear of exacerbating their condition.  As 
described by the following statements, “More than anything else my mental state is that 
I’m afraid to do some things for fear that I will have a heart attack.” and another said; 
You don’t uh…you don’t have the motivation you had before, you always have a 
shadow in the back of your mind you know, that I wouldn’t push myself to hard is 
it just could cause it worse damage or is it going to get me in better shape? 
 
Positive attitudes For some patients (36%), the experience of an ACS event 
affected their attitudes towards living and reassessing their priorities.  Patients believed 
that going forward they needed to take care of themselves for their families as well as for 
themselves. “Well, it is the attitude I have that these medications are good for me.”  And 
another shared,  
It means that I need to take better care of myself.  Give up the old habits of 
smoking, which I did a year ago, and to take my prescribed medication on time.  
Try to eat a balanced diet and try to keep my health better and my weight down, 
cholesterol down.  There’s just so many things we have to live for, we have, you 
know, grandchildren, we have three little great granddaughters and they’re from 
two years old to nine months, so.  And my wife, you know, her and I we’ve, you 
know, since high school, fifteen years old, you know, so, you know, I have a lot to 
live for so I got to watch my health. 
 
Another person shared: Going from not being used to taking any at all, to taking 
six a day…it was a little bit hard. It was a change. Lately, sometimes I forget, you 
know you get caught up in a rush or doing different things and you know, I forget. 




Establishing a Routine Utilizing a Pill Box When asked what advice patients gave 
for being adherent, patients overwhelmingly (52%) declared having a routine and/or 
using a pill box to organize the multitude of mediations.  As one man eloquently said,  
…well I realized that I was of the age that I needed to buy one of those plastic 
trays where you lay your meds for a week and you know, that becomes a bit of a 
ritual. You lay out your meds and you take them. I have also asked my family to 
help remind me and usually when they remind me I have already taking the med 
anyway, but it helps to have someone else looking out for you. 
 
Theory Generation 
 Experiencing an ACS event can be a profound, life changing event.  
Consequences of this experience vary depending on the individual.  Some patients 
become motivated to be proactive in their health behavior, while others become 
indifferent and/or depressed.  Ultimately, these consequences affect the actions and 
attitudes towards medication and health behavior adherence and the interpretation of the 
meaning of adherence. 
 Consequences of the experience can be defined in basic terms of positive and 
negative.  Those who are empowered to find affirmative aspects of their experience, 
even through fear and limitations, and are able to go forward with appropriate health 
behaviors are identified as positive in nature.  These patients are proactive participants 
in their health care: adopting healthy lifestyle behaviors, being aware of good nutritional 
habits, and adhering to the prescribed medication regimens.  They understand the 
importance of communication between patients and providers and the significance of bi-
directional relationships.  Patients who are positive understand that quality health care 
requires both the provider and the patient to be active participants in this relationship.  In 
addition, they believe that it is the patients’ responsibility to tell the provider “everything” 
and to help the providers remember specific details about themselves because providers 
are busy and have limited time with each patient.  Patients who are comfortable being 
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honest with their providers feel they are “heard” and are comfortable discussing their 
care, especially their medications.   
For patients to be comfortable being honest with their providers, the providers 
need to be patient, understanding, and take the time to discuss the details and reasons 
for each of the patient’s medications.  Thus, patients and providers build these respectful 
and equivalent ‘bi-directional’ relationships, where ultimately the patients’ are inclined to 
follow the prescribed treatment plans because they feel they are involved with the 
decision-making process of the treatment plan. 
Conversely, when the consequences of the experience result in patients who are 
consumed with fear and/or depression or who have difficulty going forward, they are 
identified as negative in nature.  Fear and depression have profound impact on patients’ 
perspectives of themselves and their outlook on life.  Fears of exacerbating their 
condition prevent people from exercising, while the fear of medication interactions and 
side effects inhibit medication adherence.  Depression caused by perceived and real 
physical limitations can affect a person’s self-identity, negatively impact their 
relationships with significant others, and subsequently, affects their self-care.  Patients 
feel less worthy and unsure of who they are and what contribution they make to the 
society, family, and themselves.  These factors hinder patients from being proactive in 
their health care. 
Communication between patients and providers is another important factor for 
patients to be proactive in their health care.  Lack of basic communication is problematic 
for patients, especially when they are consumed with fear or depression.  In order to 
obtain clear and accurate information to appropriately adjust their health behaviors, 
patients must be comfortable asking clarifying questions and sharing their opinions, even 
if they diverge from those of the providers.  Patients want to be listened to and to feel 
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heard; a perceived condescending attitude can affect how patients proceed with their 
health behavior decisions.  If patients do not understand how medications work, their 
adherence is affected.  Therefore, appropriate communication embedded in the 
respectful and equivalent ‘bi-directional’ relationship between patients and providers is 
needed to support patients’ health behavior decisions and ultimately, their actions. 
 Patients experiencing an ACS event are faced with profound health care 
decisions.  Bi-directional conversations and relationships between patients and providers 
can be a key factor of adherence to evidence-based therapies that will lead to better 
outcomes.  Patients are aware when patient-provider communication is not appropriate, 
especially when the power structure prevents an open and honest relationship.  Patients 
are aware when providers willingly involve them in the decision-making process and 
when they are not.  Yet, the traditional definition that “medication adherence usually 
refers to whether patients take their medications as prescribed (eg, twice daily), as well 
as whether they continue to take a prescribed medication” (96) does not specifically 
involve the agreed upon decision of both provider and patient.  This antiquated 
physician-centered model of care where the “doctor knows best” still exists, even though 
adherence has been defined as “the active, voluntary, and collaborative involvement of 
the patient in a mutually acceptable course of behavior to produce a therapeutic result”. 
(96, 97)   Therefore, work is needed to further disseminate and implement theories of 
patient centered care and shared decision-making models, which have been shown to: 
improve standards in care, to have positive effects on patient outcomes, and to improve 
satisfaction and adherence. (97, 98)  Yet, for the process to be effective there must first be 
an authentic communication between patient and provider, where the provider shares 
their opinion regarding the treatment options and the patient shares honestly what they 
are willing and able to do to adhere to the proposed treatment options.  This model 
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mandates that both parties are open to sharing and to hearing others opinions and 
working towards a mutually agreed upon treatment plan.  The clinician must be open to 
hear divergent opinions of what may be best for the patient, from the patients’ 
perspective.  The patient must be open to share what they will honestly do based on 
what treatment options have been proposed.  Only then can a true shared decision-





Aim 1 Gather an in-depth understanding of the pheno mena of participation in a 
pharmacist lead, multi-faceted intervention of hype rtensive patients using an 
Interactive Voice Response System and Home Blood Pr essure Monitor 
The objective of this study was to better understand patients’ experiences with a 
multifaceted intervention that included interactions between patients, healthcare 
providers, and the healthcare system.  The multifaceted intervention also required 
explicit behaviors from participants, which necessitates the need to understand what 
was effective from the perspective of the participants.  On the basis of the experiences 
shared by patients from both study arms, we propose a model to improve health 
behavior and clinical outcomes in patients with uncontrolled hypertension. As displayed 
in Figure 4, the multifaceted intervention facilitates bi-directional conversations between 
patients and healthcare providers through the IVR system.  The technology supports this 
process by providing patients with immediate feedback about home BP measurements 
and the opportunity to request follow-up calls from the pharmacist.  Furthermore, 
patients directly witness the benefits of diet, exercise, and/or medications through home 
blood pressure monitoring, which re-enforces the importance of these mediators in 
reducing BP.  Healthcare providers are able to follow patients’ home BP measurements 
and can contact them as needed to reinforce medication adherence and make 
medication dose adjustments based on the reported measurements.  The IVR reminder 
messages sent to those who have not entered home BP measurements within eleven 
days further reinforces the importance of home BP monitoring and increases contacts 
between patients and the healthcare system.  Consequently, patients feel cared for, feel 
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Figure 4 Legend.  The Theoretical Model of a Hypertension Management 
This is the proposed theoretical model to improve health behavior and clinical outcomes 
in patients with uncontrolled hypertension derived from the patients’ interviews about 





participants in their own healthcare, taking a proactive approach to medication 
adherence, monitoring their BP, and having the confidence to engage in bi-directional 
conversation with their health professionals. (25) 
The literature supports the individual components of the model that includes 
appropriate medication regimens, patient education, and addressing individuals’ needs 
for mutual working relationships with medical personnel for hypertension management. 
(25)  Previous studies have concluded that an organized system of regular follow-up, 
stepped care approach to a patients’ hypertension regimen, and integration of 
technology can improve BP control. (25)  However, the literature lacks a model that 
integrates these components into an organized system supporting patient care on 
multiple levels, which is the foundation of our theoretical framework.  In addition, there 
has been little research focusing on the participants’ perspectives of the different 
components of a hypertension intervention.  The proposed model illustrates a process 
that addresses needs of the patient, healthcare providers and the healthcare system.  
The IVR system aids in the education of the patients, serves as a repository of BP 
results, and is a liaison between the healthcare provider and the patient.  The IVR 
system provides patients with a mechanism to receive feedback about their home BP 
measurements, have questions answered, and to request pharmacist support, which 
empowers them to actively participate in their healthcare.  The IVR system also supplies 
healthcare providers with more BP measurements yielding a greater basis in which to 
make clinical decisions regarding the need to intensify therapy.  This is in contrast to 
usual clinical care, where BP measurements are only available when patients come in 
for a clinic visit, which can be stressful for some patients.  From the perspective of the 
healthcare system, this model of care delivery moves away from the traditional episodic 
based care to a more patient-centered model where care delivered is specifically 
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responsive to patient needs, (e.g., when BP is elevated or when patients request a call 
from the pharmacist) and is consistent with the chronic nature of hypertension. (25)  
Key questions in an intervention evaluation are whether or not the intervention is 
effective in everyday practice and whether or not the results vary between sites and 
among patients. (25)  This study was conducted as a practical clinical trial by selecting 
clinically relevant alternative study components to compare, including a diverse 
population of study participants, and recruiting participants from heterogeneous practice 
settings. (25)   The feedback regarding the program from participants was similar across 
sites but some differences were also noted.  We found that a higher percentage of 
African American compared to Hispanic and White patients reported an increase in 
knowledge and participation in their healthcare but a lower percentage reported being 
more empowered to interact with their PCPs.  These findings should be further explored 
in subsequent studies to potentially tailor interventions to specific patient populations. (25)  
In addition, our objective to evaluate the intervention from the patients’ perspective 
confirmed that the individual components: increased patient education, increase 
interaction with providers, and technology integrated into a multi-faceted intervention 
was indeed effective to improve patients’ health behavior to lower their blood pressures. 
Potential limitations of Aim 1 should be acknowledged.  The results of this study 
are based on the people who enrolled in the study and may be subject to attribution bias.  
In addition, there is the possibility of a social desirability bias where patients respond in a 
certain way to please the interviewer.  The study results are based only on interview 
data and did not include any direct observations of the patients using the study 
components.  Finally, there were a greater number of usual care patients with diabetes 
or chronic kidney disease and we are not aware if the presence of these co-morbidities 
had a differential impact on achievement of BP goals between the two groups. (25)     
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In conclusion, the proposed theoretical model of a clinical management system 
(Figure 4) that includes IVR, integrates patients and healthcare providers in the process 
of improving BP control.  Patients are no longer on the sidelines of their care and are 
immersed in the direct consequences of their behaviors regarding diet, physical activity, 
and medication adherence.  Healthcare professionals have the opportunity to develop a 
mutual working relationship with patients that is facilitated by technology.  When 
appropriately integrated, we believe this model will support patients to adhere to 
prescribed medical regimens that have been mutually developed and agreed upon.  The 
findings from this study can provide the framework for the development of subsequent 
interventions to change patient and healthcare provider behavior as well as clinical 
outcomes of patients with hypertension.  This model may also inform interventions for 
other chronic conditions, such as diabetes. (25)      
 
Aim 2: Assess the association of technology facilit ated interventions on 
medication adherence mediated by health behaviors 
In this study, we hypothesize that the multi-faceted intervention, Medication 
Study, would improve medication adherence after experiencing an ACS event.  In 
addition, we hypothesize that the impact of the intervention on medication adherence 
would be mediated by constructs of health behavior, as measured by the Self-Efficacy 
for Appropriate Medication Use Scale (SEAMS) and Stages of Change (SOC) 
questionnaires.   
Our findings support the primary hypothesis; the intervention significantly 
improved medication adherence compared to the usual care with a mean (SD) Recomp 
score (0.80 {0.12} vs. 0.67 {0.16} p = 0.005).  This difference is likely due to the increase 
interaction with the study pharmacist and the additional contacts via the phone 
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messages, which are components of the intervention.  These findings suggest that 
increased interactions with the healthcare system can improve medication adherence. 
The secondary hypothesis that the impact of the intervention on medication 
adherence would be mediated by constructs of health behavior is not supported.  Health 
behavior was not found to be a mediator of the association between the intervention and 
medication adherence.  Although there was no statically significant difference found, a 
greater change was seen in the control arm with both SEAMS and SOC surveys.  It 
appears the SEAMS results were affected by two extreme outliers in the control group, 
which had a greater influence on the results due to the small sample size.  Further 
sensitivity analyses were performed and indicated the outliers did have an impact, 
although not significant, on the outcome.  For the SEAMS survey, a greater change was 
seen in the intervention arm (mean change 1.80 SD 3.8) compared to the control arm 
(mean change 1.35 SD 4.75).   
In addition, the sample size was limited; therefore, the study did not have the 
power to detect a significant difference.  Going into the study, we were hoping the 
intervention would improve self-efficacy by 4 units, and planned a total sample size of 
252 to test this.  We based our calculations on Dr. Kripalani’s self-efficacy trial that 
supplied us with an effect size of four and mean standard deviation of 5.66.  This study 
would have been successful if an appropriate sample size had been obtained because 
we had sufficient power to detect a significant difference even with half the sample size.  
Unfortunately, our sample size of 42 was only 17% of the planned sample size, thus 
affecting our ability to detect a difference of four units. 
To assess the results from a clinical perspective, one could surmise that patients 
in the control group were left to their own volition to be adherent to their medication, 
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therefore becoming more motivated and confident and resulting in no significant 
differences between the two randomized groups.   
Even though a significant association between the intervention and the mediators 
was not found and therefore, there was no reason to continue with the mediation 
analysis, we decided, for the educational experience, to continue.  The exercise 
provided a tangible demonstration that clearly identified the steps involved in a mediation 
analysis and strengthened, for the doctoral student, the understanding of the mediation 
theory.   
Further investigation into mediation theory generated profound discoveries.  
Health behavior theories, including the Transtheoretical Model (TTM) identify self-
efficacy and motivation to change behaviors as specific constructs and may well be 
mediators between an intervention and an outcome.  Yet, detecting their influence in a 
mediation model may be difficult.  Mac Kinnon et al. (92) identified that the lack of an 
observed association of a mediator may be because the specific health behavior 
construct, such as self-efficacy, was not specifically targeted in the intervention.(92)  
Neither self-efficacy to adhere to cardiac medications nor motivation to change 
medication adherence behaviors were constructs specifically targeted in the Medication 
Adherence study.  In addition, Williams and Dunsiger (99) identified that the temporal 
ordering of constructs is important in the context of mediation analyses but is rarely 
achieved in practice.  Typically, measurement of the mediator and the outcome occur 
immediately prior to the intervention, at Time 1.  The mediator is measured again at 
Time 2 and the outcome at Time 3.  Thus, giving the appearance of a temporal ordering 
of constructs, yet the findings may reflect change in both the mediator and the outcome 
that occurred between Times 1 and 2 leaving the researchers unsure as to what change 
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occurred first. (97)  This dilemma would appropriately apply to our study design as we 
measured the mediator and the outcome at the same time points.   
 Williams and Dunsiger (99) offer a suggestion of measuring the mediator 
immediately prior to the intervention and immediately after the intervention and the 
outcome measured at a later point.  They believe this design may support the hypothesis 
that the change in the mediator preceded the change in the outcome.  Of course this 
design may suggest a causal relationship, a randomized control trial would be needed to 
further support the theory of causation.  In addition, they leave open the option that 
some other unmeasured construct may be the true mediating factor.  However, they 
conclude this type of evidence may be as close as we can come to supporting the 
hypothesized mediational path. 
The results of the mediation analyses, indicating a small change in the health 
behavior from baseline to 12 months and the change in health behaviors that was 
significantly associated with medication adherence, while controlling for the intervention, 
were grounds for an additional investigation.  We hypothesized that patients who began 
the study with high confidence and high motivation to take their medications were 
significantly associated with medication adherence.  Therefore, we assessed the 
association between the baseline surveys and medication adherence and found a 
significant association between both surveys and medication adherence.  These findings 
indicate that self-efficacy and motivation are predictive of medication adherence and 
although the data did not support our hypothesis, they may indeed mediate the 
relationship between the intervention and medication adherence.   
We have learned from this study that specifically targeting the mediation 
constructs in an intervention and paying strict attention to the timing of the mediation 
constructs assessment in the intervention evaluations may improve our understanding of 
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adherence behavior, which in turn may improve adherence to medications.  Self-efficacy 
and motivation are important constructs in determining patients’ ability to adhere to 
recommended medical treatment.  Therefore, before initiating cardiac therapy, 
evaluation of patients’ levels of self-efficacy and motivation should be determined. If 
those evaluations do not reflect adequate levels of self-efficacy and motivation, 
appropriate interventions aimed to improve these levels should be initiated to support 
patients’ adherence to their prescribed therapies. 
 
Aim 3: Gather patients’ perspectives of how their e xperience with multifaceted 
interventions influenced their health behavior and its effect on their health 
outcomes after experiencing an ACS event 
 The objective of this study was to better understand how a multi-faceted 
intervention designed to improve adherence to cardiac medications, impacts patients’ 
experiences after an ACS event.  We also wanted to delve further into the significance of 
bi-directional conversations between providers and patients and its effect on medication 
adherence in a post ACS population.   
 On the basis of the experiences shared by patients in the randomized control 
trial, bi-directional conversations between patients and providers is the focal point of the 
emerged theory of important factors that affect adherence to medical regimens.  Our 
theory identifies how patients respond to experiencing an ACS event, with fear or 
affirmation, initiates their journey into recovery.  The theory goes further to assess the 
importance of communication with family and friends, as well as clinical providers.  The 
communication between patients and providers must be an authentic and truthful.   
Where the provider shares their opinion regarding the treatment options and the patient 
shares honestly what they are willing and able to do to adhere to the proposed treatment 
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options.  This model mandates that both parties are open to sharing and to hearing 
others opinions and working towards a mutually agreed upon treatment plan.   
 The literature supports the individual components of our theory.  Health behavior 
theories such as the Health Belief Model (HBM) (40, 53) indicate that health actions are 
motivated by the degree of fear (perceived threat) and the expected fear reduction of 
actions, given that the reduction outweigh the barriers to taking action (net benefits).  
The HBM defines four constructs, which represent the perceived threat and net benefits.  
(40, 53) This theory supports our findings that fear was an important factor of adherence.  
Patients identified fear as a double-edged sword, with some patients sharing how fear 
motivated them to improve their health behaviors, while others told of the inability to 
exercise for fear of having another event.  Health behavior literature confirms the 
concept that fear, positive attitudes, and social support are all factors that affect patients’ 
health behavior decisions.   
Fishbein and Ajzen’s Theory of Reasoned Action (40, 53) supports our findings that 
positive attitude and social support affect adherence behavior.  According to this theory, 
a patient’s intention to perform a specific behavior is a function of two individual factors: 
their attitude, either positive or negative, toward the behavior and the influence of the 
social environment (norms) on the behavior.  Attitudes are a function of beliefs.  If people 
believe that performing a behavior will lead to a positive outcome then they will have a 
positive attitude performing that behavior.  The social norms are the patients’ beliefs that 
certain individuals or groups believe the patients should or should not perform the 
defined behavior. (40, 53)  In addition, a recent systematic review by Scheurer et al. (101) 
found that practical social support was most consistently associated with greater 
medication adherence. (101)  The multiple studies included in the review, as well as the 
results of the review, back our findings that patients in our study indicated their 
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adherence was supported by family and friends. Thus, our results are in concordance 
with the previous literature regarding positive attitudes, social support, and fear 
constructs. 
Further concordance with the literature includes the World Health Organization 
(50) categorizing potential reasons for medication non-adherence and four of the five 
groupings included the health system (providers and system factors), the condition 
(ACS), the patient (deciding to adhere or not), and the therapy (side effects).  It has also 
been documented that poor relationships and poor communication between providers 
and patients affects non adherence. (3-7, 48-50, 92)  In addition, the concept of shared 
decision-making (SDM), which debuted in the 1980’s has similar conclusions.  The 
original focus of SDM was on potentially life threatening illnesses, it is now expanding 
into all aspects of clinical practice. (102-103) SDM is defined as “an approach where 
clinicians and patients share the best available evidence when faced with the task of 
making decisions, and where patients are supported to consider options, to achieve 
informed preferences.” (103)  Elwyn et al. (103) go further to describe that the skills of SDM 
are unlikely to be developed unless the provider agrees with the guiding ethical 
principles.  At the core of SDM is the acceptance that individual self-determination is a 
desirable goal and that providers need to support patients to achieve this goal, wherever 
feasible. (103)  SDM is very supportive of our findings of open communications, supporting 
patients to be involved in their healthcare, and encouraging patients to distribute their 
deliberation process (i.e. talk with their family and friends). (103)  Although, if a provider 
does not agree with the guiding ethical principles of shared decision-making, they are 
unlikely to be willing to participate in the process of shared decision-making and 
accepting that individual self-determinations is a desirable goal. (97, 103)  Thus, for the 
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model to be successful, both parties of the clinical encounter need to understand and be 
willing to participate in the process 
Our findings fill the gap in the literature on medication adherence by using bi-
directional communication between provider and patient to go deeper into the shared 
decision-making process.  At the present time, numerous studies describe decision-
making tools, which may be no more than additional information used to persuade 
patients to follow the evidenced based treatment options.  Bi-directional conversations 
help to remove barriers of communication and empower patients to share concerns, 
fears, and personal issues giving the provider important information regarding potential 
barriers to adherence (social and psychological states and issues).  Therefore, bi-
directional conversations and relationships allow exploration to empower patients to be 
active participants in their healthcare and give providers the opportunity to understand 
the honest adherence behavior of their patients and to assess true treatment 
effectiveness, which may improve health outcomes. 
The objective of this study was also to better understand patients’ experiences 
with a multifaceted intervention that included interactions between patients, healthcare 
providers, and the healthcare system.  The multifaceted intervention required minimal 
behaviors from participants, yet we need to understand what was effective from the 
perspective of the participants.  The increased interaction with the pharmacist supported 
patients with their medication adherence.  The one-on-one personal interactive 
relationship allowed bi-directional conversations to occur that addressed patients’ 
concerns with their medications.  Questions, clarifications, and explanations went as 
deep as the patient needed to understand why and how to adhere to the prescribed 
regimen.  The pharmacist reconciled any medication issues, attempted to synchronize 
the refill dates of the cardiac medications so that refills all occurred on the same date, or 
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as close as possible, instead of usual practice where medication refill dates vary 
tremendously.  The pharmacist also educated the patient about the importance of their 
medications and provided a pill box.  This bi-directional relationship was available 
throughout the study period and supported the intervention patients in adhering to the 
prescribed cardiac medications.   
The intervention incorporated phone messages to support patients by reminding 
them to refill their cardiac medications and the importance of adherence to medications 
and life style changes.  This increased interaction with the healthcare system was a 
positive experience for some patients, as one patient said that he felt cared about due to 
receiving the messages.    
Thus, based on the feedback from the patients’ both positive and negative we 
can conclude that the individual components: increased patient education, increase 
interaction with providers, and technology integrated into this multi-faceted intervention 
was indeed effective to improve patients’ health behavior to adhere to their medication 
and life style changes.  The feedback about the phone messages being annoying after 
the mediation were refilled and not knowing which medication needed to be refilled will 
be helpful for improving the system.   
In conclusion, patients experiencing an ACS event are faced with profound 
health care decisions.  Evidence-based medicine indicates that health behavior 
decisions have substantial consequences on clinical outcomes.  Improving health 
behavior decisions, especially adherence to medical regimens known to improve 
outcomes, is a complex process that includes all facets of the healthcare system.  This 
study focuses on the significance of the interaction between the patient and the provider 
and the importance of how technology facilitates the interaction.  These profound 
relationships, which utilize open communication and bi-directional relationships, affect 
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the health behaviors of patients and may have strengthened the impact on clinical 
outcomes. , bi-directional conversations give patients’ the confidence to honestly share 
their health behavior limitations, which in turn give providers the honest depiction of what 
the patient will do and therefore, can ascertain the most appropriate treatment options.  
Providers will also be given insight into the real effectiveness of their treatment plans. 
 
Integration of Aims 1-3 
The primary purpose of this thesis was to gather an in-depth understanding of 
the experience of participating in technology facilitated multifaceted cardiac interventions 
and how the interventions affect health behavior decisions from the patients’ 
perspective.  The secondary purpose was to assess the association of the impact of 
technology facilitated interventions with cardiovascular outcomes mediated by health 
behavior.  To accomplish these goals, we completed three distinct aims in which the 
patient populations were derived from two cardiovascular randomized controlled clinical 
trials.  After completion of the individual aims, we merged the data to triangulate the 
findings.  By combining the patients’ perspectives and the study outcomes, we were 
better able to understand the patients’ experiences of participating in these multifaceted 
interventions and the effect of the interventions on their health behaviors. 
Triangulating the data was important to fully understand the complexity of the 
effect of the interventions on patients’ behavior.  Multifaceted interventions provide 
options for resources and advice, which may be welcomed, heeded, and acted upon.  
What this means is that patients select medical advice or aspects of interventions they 
believe to be beneficial or conducive to their lifestyle.  This preferential uptake of 
intervention components potentially affects the outcome of the study.  Understanding 
96 
 
which components patients adopt and the reasons for their choices are important 
towards understanding why interventions are effective.  
Therefore, we used both qualitative and quantitative data for the inquiry.  The 
qualitative data revealed that the patients’ experiences during the intervention affected 
their health behaviors.  Most patients indicated that overall, the interventions positively 
affected their health behaviors.  Patients in the “Improving BP in Colorado” (Aim 1) said 
that they were no longer on the sidelines of their care and instead were aware of the 
direct consequences of their behaviors regarding diet, physical activity, and medication 
adherence.  The home BP monitors, the IVR system, and the increased interaction with 
the study pharmacists were the individual components to the intervention.  Each 
component individually and collectively supported the patient to improve their health 
behavior.  For example, patients shared that the BP monitor allowed them to see the 
effects of medication adherence.  The IVR and the pharmacists were very important 
because from their interactions the patients increased their knowledge of their 
healthcare needs, felt cared for, and empowered the patients to take control of their 
healthcare.  Therefore, they were more inclined to eat healthier food, exercise more, and 
take their medications as prescribed.  These results were fully supported by the 
quantitative findings of a significant improvement of the systolic blood pressures in the 
intervention group compared to the control group.  Patients in the “Medication Study” 
(Aim 3) also indicated that the intervention improved adherence behaviors.  The 
increased interaction with the study pharmacists was again important for the same 
reason of feeling cared for.  The participants shared that the Medication Study’s phone 
messages reminded them to refill their cardiac medications and reinforced the 
importance of adherence to medications and life style changes.  These results were 
likewise fully supported by the quantitative findings of a significant improvement the 
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cardiac medication adherence in the intervention group compared to the control group.  
The quantitative data also elucidated a positive association of the Medication Study with 
health behavior constructs self-efficacy (empowerment) and motivation to adhere to 
medications.  Thus, triangulation of data allowed us to understand specific components 
patients adopted and the reasons for their choices, which is important towards 
understanding why interventions are effective. 
The qualitative interviews gave us further insight into the importance of feeling 
cared about and of developing bi-directional conversations, which augment these 
feelings.  Bi-directional conversations are defined as discussions that flow from the 
provider to the patient and from the patient back to the provider and require both the 
provider and the patient to be active participants in the discussion.  The patients’ 
responsibility is to be honest with the provider, which helps providers to know specific 
details about the patients’ health behaviors.  Patients who are comfortable being honest 
with their providers feel they are “heard”, feel cared about, and are comfortable 
discussing their care.  Yet, for patients to be comfortable being honest with their 
providers, the providers need to be open to hear the patients’ perspective without 
judgment.  The provider needs to be patient, understanding, and take the time to discuss 
the details and reasons for the prescribed treatment plan.  The bi-directional 
conversations increased patients’ knowledge about appropriate health behaviors, health 
issues and medication.  For the providers, the bi-directional conversations gave 
providers truthful information about the patients.  Thus, patients and providers build 
respectful and equivalent relationships.  These relationships embody the caring 
phenomenon and further support patients’ to improve health behaviors.   
These respectful and equivalent relationships help to empower patients and 
remove barriers of communication.  Removing the barriers of communication, empowers 
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patients to share preferences, concerns, fears, and personal issues giving the provider 
important information regarding potential barriers to adherence (social and psychological 
states and issues).  This allows patients to work with the providers towards mutually 
agreed upon treatment plans because they are involved with the decision-making 
process of the treatment plan.  Given the honest depiction of the treatment plan, 
providers are given insight into the real effectiveness of their treatment plans.  Therefore, 
appropriate communication embedded in the respectful and equivalent bi-directional 
relationship between patients and providers support both patients and providers to fulfill 
their role in the healthcare treatment model. 
Using a mixed methodology we were able to explore the proposed questions and 
hypotheses to understand deeper insight into evaluating the effectiveness of 
multifaceted interventions and the relationship between the quantitative findings and the 
phenomenon of experiencing the intervention from the perspective of participants.  Had 
we only used quantitative data, we would not have been able to discern which 
components of the intervention patients believed to be important.  Utilizing qualitative 
methodologies allowed us to tease out factors that supported positive health behaviors 
(feeling cared about, increased interactions healthcare, bi-directional relationships).  In 
addition, we were able to explore the reasoning of negative health behaviors (fear, 
disagreement with prescribed treatment).  Equally, using only qualitative data would limit 
our ability to assess the objective effectiveness of the intervention.  This pragmatic 
approach enabled us to examine the practical consequences and empirical findings of 
the multifaceted interventions to decide which factors were effective and should be 
maintained in the intervention to improve the outcomes (increased interactions with 
health providers, IVR, screening of self-efficacy).  Consequently, this pragmatic 
paradigm was ideal for inquiry into this health services research where the intent was to 
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evaluate and foster effective interventions to improve quality of care, specifically in the 
CVD population.  CVD outcomes is a challenge, this thesis adds important information 
and insights to the literature to better understand patients’ perspectives regarding their 
CVD treatment, health behaviors, and outcomes.   
Next Steps 
To expand this research, next steps will need to explore the efficacy of utilizing 
bi-directional conversations in a shared decision-making model (SDM).  SDM is the 
contemporary health care model and for it to be successful bi-directional relationships 
need to be an important component.  Yet, the literature indicates that the skills of SDM 
are unlikely to be developed unless the provider agrees with the guiding ethical 
principles.  Therefore, we believe an assessment of providers and administrators’ 
biases, and perceptions of barriers and facilitators of establishing bi-directional 
conversations and relationships in the healthcare environment needs to be obtained.   
Additionally, we hypothesize that it is not cost effective to have PCPs develop 
these relationships due to the time commitment need to develop the relationship.  Thus, 
a model that includes Health Coaches provided with training in performing bi-directional 
conversations in a shared decision-making model could be explored for efficacy and cost 
effectiveness.   
Finally, based on our findings, we believe development of a screening 
questionnaire that includes specific constructs that either supported or hindered patients’ 
ability to follow through with healthy behaviors is needed.  Specific constructs include: 
increased interactions with pharmacists, nurses, or other healthcare providers; reminder 
systems; home monitoring, educational programs; exercise programs.  In addition, the 
questionnaire would include components that the literature identifies to be important 
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constructs in determining patients’ ability to adhere to recommended medical treatment: 
depression, self-efficacy, motivation, health literacy, and cognitive impairment.   
In conclusion, these future steps will further explore ideas and concepts identified 
by patients and researchers through the inquiry of this thesis. 
 
Limitations 
Potential limitations of the study should be acknowledged.  The results of this 
study are based on the people who enrolled in the studies and may be subject to 
attribution bias.  Thus, the experience of participation in the study may have influenced 
participants’ perspectives of their interactions with their providers.  However, we also 
interviewed control patients who only received usual care, therefore, we obtained 
balanced perspectives.  In addition, there is the possibility of a social desirability bias 
where patients respond in a certain way to please the interviewer, and may not have 
truly reflected their opinions of the study.  Yet, because the interviewers were not in any 
power structured role, we believe patients were not influenced to please the 
interviewers.  The qualitative study results are based only on interview data and did not 
include any direct observations of the patients using the intervention components.  In 
addition, systematic differences of the interviewers may have impacted the results.  
Therefore, varied results may have emerged that otherwise would have been more 
consistent.  Furthermore, less sophisticated interviewers may not have delved as far into 
the perspectives of subjects than more advanced may have, thus missing potentially 
important data. However, the data was evaluated by a multidisciplinary group who were 
able to interpret the findings in a broader context. 
The number of quantitative surveys obtained was dependent on the site decision 
to participate or not in this sub-analysis, thus affecting our ability to detect a difference.  
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Self-report survey data may be affected by recall bias or the desire to please.  However, 
because the interviewers were not in any power structured role, we believe patients 
were not influenced to please the interviewers.  Finally, the Recomp method used to 
assess the medication adherence does not exactly determine actual usage of 
medications by patients, we were unable to identify discontinued medications, and the 
inability to assess outside hospitalization may affect the results.  These limitations may 
have affected our conclusions of the adherence pattern of the subjects in this analysis.  
However, this methodology is the most appropriate to assess multiple medications taken 
across multiple classes, which the literature has identified improve clinical outcomes, 
such as control of hypertension, which are a function of adherence to the regimen rather 
than to individual medications.  
In conclusion, we do not believe the identified limitations of this thesis bias the 
results due to the mixed methodology and triangulation of the data that allowed us to test 
for consistency.  Understanding inconsistencies from different types of data that are 
sensitive to alternative aspects of the phenomenon in question offered deeper insight 











1. Heart Disease and Stroke Statistics 2012 Update : A Report From the American Heart 
Association http://circ.ahajournals.org/content/early/2011/12/15/CIR.0b013e31823ac046 
Circulation published online December 15, 2011. Accessed February 14, 2012. 
 
2. Centers for Disease Control and Prevention Chronic Disease Prevention and Health 
Promotion Page last updated: January 5, 2011    
http://www.cdc.gov/chronicdisease/resources/publications/AAG/dhdsp.htm Accessed 
January 22, 2012. 
 
3. Haynes R, McDonald H, Garg A. Helping patients follow prescribed treatment: clinical 
applications. JAMA. 2002; 22: 2880-3. 
 
4. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to 
treatment: three decades of research. A comprehensive review. Journal of Clinical 
Pharmacy and Therapeutics. 2001; 26:331-42. 
 
5. Van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Furthering 
patient adherence: a position paper of the international expert forum on patient 
adherence based on an internet forum discussion. BMC Health Services Research. 
2008; 8:47. 
 
6. Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 
2005; 353:487-97. 
 
7. Garner, J. Problems of Nonadherence in Cardiology and Proposals to Improve 
Outcomes.  American Journal of Cardiology. 2010; 105: 1495-501. 
 
8. Lowry, K., Dudley, T., Oddone, E., & Bosworth, H. Intentional and unintentional 
nonadherence to antihypertensive medication. Annals of Pharmacotherapy. 2005; 
39:1198-203. 
 
9. Magid D, Ho P, Welch L, Olson K, Snow K, Lambert-Kerzner A,  Brand DW, 
Plomondon ME, Havranek EP. Improving Blood Pressure in Colorado.  American Heart 
Association abstract presented April 24 –April 25, 2009.  
 
10. Bosworth H, Olsen M, Grubber J, Neary A, Orr M, Powers B, Adams M, Svetkey L, 
Reed S, Li Y, Dolor R, Oddone E. Two self-management interventions to improve 
hypertension control. Annals of Internal Medicine.  2009; 151:687-95. 
 
11. Green B, Cook A, Ralston J, Fishman P, Catz S, Carlson J, Carrell D, Tyll L, Larson 
E, Thompson,R. Effectiveness of home blood pressure monitoring, web communication, 
and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008; 
299:2896-2898.   
 
12. Krishna S, Balas E, Boren S, Maglaveras N. Patient acceptance of educational voice 
messages: a review of controlled clinical studies.  Methods of Information in Medicine. 
2002; 41:360-9.     
103 
 
13. Mehos B, Saseen J, MacLaughlin E. Effect of pharmacist intervention and initiation 
of home blood pressure monitoring in patients with uncontrolled hypertension.  
Pharmacotherapy. 2000; 20:1384-1389. 
 
14. McManus R, Mant J, Bray E, Holder R, Jones M, Greenfield S, Kaambwa B, Banting 
M, Bryan S, Little P, Williams B, Hobbs F. Telemonitoring and self-management in the 
control of hypertension (TASMINH2).  Lancet. 2010;376:163-7BMC Cardiovascular 
Disorders. 22. 
 
15. Piette JD. Interactive voice response systems in the diagnosis and management of 
chronic disease. Am J Manag Care. 2000;6:817-27. 
 
16. Piette JD, Kraemer FB, Weinberger M, McPhee SJ. Impact of automated calls with 
nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs 
Health Care System. Diabetes Care. 2001;24:202-8.  
 
17. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring 
and counseling patients with hypertension. Impact on medication adherence and blood 
pressure control. Am J Hypertens. 1996;9:285-92. 
 
18. Magid D, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, Lambert-Kerzner AC, 
Plomondon ME, Havranek EP.  A multimodal blood pressure control intervention in 3 
healthcare systems. Am J Manag Care. 2011; 17:e96-103. 
 
19. Stacy JN, Schwartz SM, Ershoff D, Sheve MS. Incorporating tailored interactive 
patient solutions using interactive voice response technology to improve statin 
adherence: results of a randomized clinical trial in a managed care setting. Population 
Health Management. 2009; 12:241-54. 
 
20. Misono AS, Cutrona SL, Choudhry NK, Fischer MA, Stedman MR, Liberman JN, 
Brennan TA, Jain SH, Shrank WH. Healthcare Information Technology Interventions to 
Improve Cardiovascular and Diabetes Medication Adherence. Am J Managed Care. 
2010;16:SP82-SP92. 
 
21. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X.  Interventions for enhancing 
medication adherence. Cochran Database Systematic Review. 2008;16; (2) CD000011.  
 
22. Reidel K, Tamblyn R, Patel V, Huang A.  Pilot study of an interactive voice response 
system to improve medication refill compliance.  BMC Medical Informatics and Decision 
Making.  2008:8:46. 
 
23. Fahey T, Schroeder K, Ebrahim S. Interventions used to improve control of blood 
pressure in patients with hypertension. Cochrane Database System Reviews.; 2006. (4) 
CD005182. DOI: 10.1002/14651858.CD005182.pub3. 
 
24. Egan B, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and 





25. Lambert-Kerzner A, Havranek EP, Plomondon M, Albright K, Moore A, Gryniewicz K, 
Magid D, Ho PM. Patients’ Perspectives of a Multifaceted Intervention with a Focus on 
Technology: A Qualitative Analysis. Circulation Cardiovascular Quality and Outcomes. 
2010; 3:668-674. 
 
26. Pawson R. Evidence-based policy: A realist perspective. London, Sage Publications 
Ltd.; 2006. 
 
27. Lenio J. Analysis of the Transtheoretical Model of Behavior Change.  Journal of 
Student Research University of Wisconsin 5th Edition 2006.  
 
28. U. S. Department of Health and Human Services National Institute of Health. (2005). 
Theory at a Glance A Guide for Health Promotion Practice Second Edition. Accessed 
March 27, 2012. http://www.cancer.gov/cancertopics/cancerlibrary/theory.pdf 
 
29. Norcross JC, Krebs PM, Prochaska JO. Stages of Change. Journal of Clinical 
Psychology: In Session. 2011;67:143-154. 
 
30. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS.  
The process of smoking cessation: an analysis of precontemplation, contemplation, and 
preparation stages of change. Journal of Consult Clinical Psychology. 1991; 59:295-304. 
 
31. Prochaska J, Velicer W.  The Transtheoretical model of health behavior change.  
American Journal of Health. 1997; 12:38-48. 
 
32. Ulin PR,Robinson ET, Tolley EE. Qualitative Methods in Public Health  A Field Guide 
for Applied Research, Jossey-Bass A Wiley Imprint; 2005. 
 
33. Creswell J. Qualitative Inquiry and Research Design. 2nd ed. Thousand Oaks, Ca: 
Sage Publications Ltd.; 2007. 
 
34. Curry L, Nembhard I, Bradley E. Qualitative and Mixed Methods Provide Unique 
Contributions to Outcomes Research. Circulation. 2009;119:1442-1452. 
 
35. Johnson RB, Onwuegbuzie AJ.  Mixed Methods Research: A Research Paradigm 
Whose Time Has Come. Education Researcher. 2004; 33:14-26. 
 
36. Creswell J. Plano Clark V. Designing and Conducting Mixed Methods Research, 
Thousand Oaks, Sage Publications Ltd.; 2007. 
 
37. Craig P, Dieppe P, MacItyre S, Mitchie S, Nazareth I, Petticrew M. Developing and 
evaluating complex interventions: the new Medical Research Council Guidance. British 
Medical Journal. 2008; 337:979-83. 
 
38. Campbell N, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, Guthrie B, 
Lester H, Wilson P, Kinmonth A. Designing and evaluating complex interventions to 
improve health care. British Medical Journal. 2007; 334:455-59. 
 
39. Glanz,K. Lewis F,Rimer B. Health Behavior and Health Education. San Francisco, 
Jossey-Bass Publishers; 1990.  
105 
 
40. Mississippi Agricultural and Forestry Experiment Station Mississippi State University 
Extension Service.  Health & Nutrition: Human Health. Health Education Behavior 
Models and Theories – A Review of the Literature – Part 1. 
http://msucares.com/health/health/appa1.htm 
 Accessed August 26, 2010. 
 
41. U.S. National Library of Medicine National Institutes of Health. 
http://www.nlm.nih.gov/pubs/factsheets/medline.html.  Accessed February 1, 2012.  
 
42. PubMed including MEDLINE.  National Center for Biotechnology Information (NCBI) 
http://www.ncbi.nlm.nih.gov/books/NBK3827/#pubmedhelp.PubMed_Quick_Start 
 
43. U.S .Department of Health and Human Services National Institutes of Health 
National Heart, Lung, and Blood Institute. The Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC 7) National High Blood Pressure Education Program. Hypertension. 2003. 42: 
1206-1252. http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf. Accessed 
February 1, 2012. 
 
44. United States Department of Health and Human Services (USDH&HS), National 
Institutes of Health,National Heart Lung and Blood Institute. 
http://www.nhlbi.nih.gov/health/health-topics/topics/heartattack/ Accessed February 19, 
2012. 
 
45. Baltimore Washington Medical Center, University of Maryland Medical System. 
http://health.bwmc.umms.org/patiented/articles/what_coronary_artery_disease_000003_
1.htm Accessed February 19, 2012. 
 
46. Ischemic Heart Disease. Veterans Administration Quality Enhancement Research 
Initiative (VA QUERI) Fact Sheet.  Updated June 2011. 
http://vaww.queri.research.va.gov/about/factsheets/idh_factsheet.pdf. Accessed 2/20/12. 
 
47. Lambert-Kerzner A, Del Giacco EJ, Fahdi IE, Bryson CL, Melnyk SD, Bosworth HB, 
Davis R, Mun H, Weaver J, Barnett C, Radcliff T, Hubbard A, Bosket KD, Carey E, 
Virchow A, Mihalko-Corbitt R, Kaufman A, Marchant-Miros K, Ho PM; on behalf of the 
Multifaceted Intervention to Improve Cardiac Medication Adherence and Secondary 
Prevention Measures (Medication) Study Investigators. Patient-Centered Adherence 
Intervention After Acute Coronary Syndrome Hospitalization.  Circ Cardiovasc Qual 
Outcomes. 2012;5:571-576. 
 
48. Gazmararian J, Kripalani S, Miller M, Echt K, Ren J, Rask K. Factors associated with 
medication refill adherence in cardiovascular-related diseases: a focus on health literacy. 
Journal of General Internal Medicine. 2006; 21(12):1341-2. 
 
49. Lynch T. Medication costs as a primary cause of non-adherence in the elderly. The 
Consultant Pharmacists. 2006; 21(2):143-6. 
 





51. Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. 
Psychological Review. 1977;84:191-215. 
 
52. Bandura A Self-efficacy mechanism in human agency. American Psychologist. 1982; 
37:122-147. 
 
53. Redding CA, Rossi JS, Rossi SR, Velicer WF, Prochaska JO.  Health Behavior 
Models The International Electronic Journal of Health Education. 2000; 3 (Special 
Issue): 180-193 
 
54. Creswell JW, Klassen AC, Plano Clark VL, Smith KC for the Office of Behavioral and 
Social Sciences Research. Best practices for mixed methods research in the health 
sciences. August 2011. National Institutes of Health. Date retrieved 9/14/12. 
http://obssr.od.nih.gov/mixed_methods_research  
 
55. Neale B, Flowerdew J, Time. Texture and Childhood: The Contours of Longitudinal 
Qualitative Research International Journal of Social Research Methodology. 2003;6 (3): 
189-199. 
 
56. Patton M. Qualitative Research & Evaluation Methods. 3rd ed. Thousand Oaks, Ca: 
Sage Publications Ltd.; 2002. 
 
57. Bradley E, Curry L, Devens K. Qualitative Data Analysis for Health Services 
Research: Developing Taxonomy, Themes, and Theory. Health Services Research. 
2007;42:4. 
 
58. Ahern DK, Woods SS, Lightowler MC, Finley SW, Houston TK. Promise of and 
Potential for Patient-Facing Technologies to Enable Meaningful Use American. Journal 
of Preventive Medicine. 2011; 40: S162-S172. 
 
59. Lee H, Friedman, ME, Cukor P, Ahem D. Interactive voice response system (IVR) 
in health care services. Nurs Outlook. 2003;51:277–283 
 
60. Androwich I, Kraft MR.  Use of Interactive Voice Response Technology in Health 
Care. Veterans Affairs Health Services Research and Development Cyber Seminars. 
http://www.hsrd.research.va.gov/cyberseminars/catalog-search.cfm . Presented 
February 24, 2011. 
 
61. Corkrey R, Parkinson L. Interactive voice response: review of studies 1989-2000. 
Behavior Research Methods, Instruments, & Computers. 2002;34:342-53. 
 
62. Krishna S, Balas E, Boren S, Maglaveras N. Patient acceptance of educational voice 
messages: a review of controlled clinical studies.  Methods of Information in Medicine. 
2002; 41:360-9. 
 
63. Glanz K, Shigaki D, Farzanfar R, Pinto B, Kaplan B, Friedman R.  Participant 
reactions to a computerized telephone system for nutrition and exercise counseling. 




64. Kaplan B, Farzanfar, Friedman R. Personal relationships with an intelligent 
interactive telephone health behavior advisor system: a multimethod study using surveys 
and ethnographic interview. International Journal of Medical Informatics. 2003; 71:33-41. 
 
65. American Heart Association website 
http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/SymptomsDiagnosisM
onitoringofHighBloodPressure/Home-Blood-Pressure-
Monitoring_UCM_301874_Article.jsp.  Accessed April 19, 2012. 
 
66. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, 
Sheps SG, Roccella EJ.  AHA Scientific Statement - Recommendations for Blood 
Pressure Measurement in Humans and Experimental Animals Part 1: Blood Pressure 
Measurement in Humans: A Statement for Professionals From the Subcommittee of 
Professional and Public Education of the American Heart Association Council on High 
Blood Pressure Research. . Hypertension. 2005; 45: 142-161. 
 
67. Pope C and Mays N. Qualitative Reseach Reaching the parts other methods cannot 
reach: an introduction to qualitative methods in health and health services research. 
BMJ. 1995;311:42-5.   
 
68. Hsieh HF, Shannon SE.  Three approaches to qualitative content analysis. 
Qualitative Health Research.  2005; 15:1277-1288. 
 
69. Berg BL. Qualitative Research Methods for the Social Sciences.  Boston: Allyn and 
Bacon. 2001. 
 
70. The Grounded Theory Institute. The official site of Dr. Barney Glaser and Classic 
Grounded Theory.  http://www.groundedtheory.com. Accessed July 19, 2012.   
 
71. Charmaz K. Constructing Grounded Theory – A Practical Guide Through Qualitative 
Analysis. London. Sage Publications Ltd. 2006. 
 
72. Heisler M, Piette J.  “I Help You, and You Help Me” Facilitated Telephone Peer 
Support Among Patients With Diabetes. The Diabetes Educator.  2005;31:869. 
 
73. Jones MI, Greenfield SM, Bray EP, Baral-Grant S, Hobbs FR, Holder R, Little P, 
Mant J, Virdee SK, Williams B, McManus RJ.  Patients’ experiences of self-monitoring 
blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. 
British Journal of General Practice. 2012;62:135-142. 
 
74. Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourn K, Mitty 
J, Caro JJ. Stages of Change for Adherence with Medication Regimens for Chronic 
Disease: Development and Validation of a Measure. Clinical Therapeutics. 2000;22:858-
871. 
 
75. Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the 
Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with 




76. Bruce CM, Jacobson TA, Vaccarino V, Kripalani S. “Effect of a Low-Literacy 
Intervention on Self-Efficacy and Medication Adherence”  Abstract.  Health Literacy 
Annual Research Conference, Chicago, IL. October 16, 2011.  
 
77. Ficke DL, Farris KB. Use of the Transtheoretical Model in the Medication Use 
Process. Annals of Pharmacotherapy. 2005;39:1325-1330. 
 
78. Johnson SS, Driskell MM, Johnson JL, Prochaska JM, Zwich W, Prochaska JO.  
Efficacy of Transtheoretical Mode l-Based Expert System For Antihypertensive 
Adherence. Disease Management. 2006;9:291-301. 
 
79. Johnson SS, Driskell MM, Johnson JL, Dyment SJ, Prochaska JO, Prochaska JM, 
Bourne L. Transtheoretical model intervention for adherence to lipid-lowering drugs. 
Disease Management. 2006; 9:102-114. 
 
80. Finnell DS, Osborne FH. Stages of Change for Psychotropic Medication. Archives of 
Psychiatric Nursing. 2006; 20:166-74. 
 
81. Miller DI, Bruce H, Gagnon M, Talbot V, Messier C. Improving Older Adults’ 
Experience with Interactive Voice Response Systems. Telemedicine and e-Health. 
2011;17:452-455. 
 
82. McTigue KM, Bhargava T, Bryce C, Conroy M, Fischer G, Hess R, Simkin-Silverman 
LR, Zickmund S. Patient Education Counseling. 2011;83:261-4. 
 
83. Haberer JE, Kiwanuka DN, Wilson IB, Bangsberg DR. Challenges in Using Mobile 
Phones for Collection of Antiretroviral Therapy Adherence Data in a Resource-Limited 
Setting. AIDS Behavior. 2010;14:1294-1301. 
 
84. O’Grady L. Consumer e-health education in HIV/AIDS: a pilot study of a web-based 
video workshop. BMC Medical Informatics and Decision Making. 2006. 6-10. 
 
85. Lofland J, Lofland LH. Analyzing Social Settings: A Guide to Qualitative Observation 
and Analysis. 2nd ed. Belmont, CA: Wadsworth Publishing; 1984. 
 
86. Stemler S. An overview of content analysis. Practical Assessment, Research and 
Evaluation [website]. Available: http://PAREonline.net/getvn.asp?v=7&n=17. Accessed 
May 25, 2009. 
 
87. Graneheim U, Lundman B. Qualitative content analysis in nursing research: 
concepts, procedures and measures to achieve trustworthiness. Nurse Ed Today. 2004; 
24:105-12. 
 
88. Giacomini MK, Cook DJ. Users' guides to the medical literature: XXIII. Qualitative 
research in health care  Are the results of the study valid? JAMA. 2000; 284:357-362. 
 
89. Glasner B, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative 




90. Baron RM, Kenny DA. Moderator‐Mediator Variables Distinction in Social 
Psychological Research: Conceptual, Strategic, and Statistical Considerations,” Journal 
of Personality and Social Psychology. 1986; 51:1173–82. 
 
91. Sobel ME. Effect Analysis and Causation in Linear Structural Equation Models. 
Psychometrika. 1990; 55: 495-515. 
92. MacKinnon DP, Fairchild AJ, Fritz MS. Mediation Analysis. Annual Review of 
Psychology. 2007; 58:593-614. 
 
93. MacKinnon DP, Fritz MS, Williams J, Lockwood CM. Distribution of the product 
confidence limits for the indirect effect: Program PRODCLIN. Behavior Research 
Methods. 2007; 39:384-389. 
 
94. SAS Version 9.3 SAS Instutute Inc, Cary, NC, USA  
 
95. Atlas.ti Version 6.2 Scientific Software Development GmbH. 
 
96. Ho PM, Bryson CL, Rumsfeld JS. Medication Adherence Its Importance in 
Cardiovascular Outcomes. Circulation. 2009;119:3028-3035. 
 
97. Karnieli-Miller O, Eisikovits Z. Physician as partner or salesman? Shared decision-
making in real-time encounters. Social Science & Medicine. 2009;69:1-8. 
  
98. Dy SM, Purnell TS. Key concepts relevant to quality of complex and shared 
decidion-making in health care: A literature review. Social Science & Medicine. 2012;  
74:582-587. 
 
99. Williams DM, Dunsiger S. Suggestions for Testing Health Behavior Theories 
Implications for Mediator Analysis. Annals of Behavioral Medicine. 2007; 34:223. 
 
100. Ramalho-de Oliverira D, Shoemaker SJ, Ekstrand M, Alves MR. Preventing and 
resolving drug therapy problems by understanding patients’ medication experiences.  
Journal of the American Pharmacists Association. 2012;52:71-80. 
 
101. Scheurer D, Choudhry N, Swanton KA, Matlin O, Shrank W.  Association Between 
Different Types of Social Support and Medication Adherence. American Journal of 
Managed Care. 2012;18:e461-e467. 
 
102. Charles C, Gafni A, Whelan T. Shared Decision-Making in the Medical Encounter: 
What Does it Mean? (Or it takes at least two to tango). Social Science Medicine. 
1997;44:681-692. 
  
103. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording 
E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M. Shared Decision Making: A 









Self-efficacy for Appropriate Medication Use Scale (SEAMS) 
 
 
How confident are you that you can take your medici nes correctly….. 
 
(1)  When you take several different medicines each day. 
 Not confident   Somewhat confident   Very confident 
 
(2) When you take medicines more than once a day. 
 Not confident   Somewhat confident   Very confident 
 
(3) When you are away from home. 
 Not confident   Somewhat confident   Very confident 
 
(4) When you have a busy day planned. 
 Not confident   Somewhat confident   Very confident 
 
(5) When they cause some side effects. 
 Not confident   Somewhat confident   Very confident 
 
(6) When no one reminds you to take the medicine. 
 Not confident   Somewhat confident   Very confident 
 
(7) When the schedule to take the medicine is not convenient. 
 Not confident   Somewhat confident   Very confident 
 
(8) When your normal routine gets messed up. 
 Not confident   Somewhat confident   Very confident 
 
(9)  When you are not sure how to take the medicine. 
 Not confident   Somewhat confident   Very confident 
 
(10) When you are not sure what time of day to take your medicine. 
 Not confident   Somewhat confident   Very confident 
 
(11)  When you are feeling sick (you know, like having a cold or the flu). 
 Not confident   Somewhat confident   Very confident 
 
(12)  When you get a refill of your old medicines and some of the pills look different 
than usual. 
 Not confident   Somewhat confident   Very confident 
 
(13)  When a doctor changes your medicines. 










Stages of Change for Medication Adherence 
 
 
1. People sometimes find it difficult to take their medication as directed by their 
physician. As directed means consistently taking the amount of medication prescribed by 
your physician at the time(s) prescribed by your physician. Please find the statement that 
best describes the way you feel right now about taking your (high blood 
pressure/protease inhibitor) medication as directed. 
 
A. No, I do not take and right now am not considering taking my medication as 
directed.  
 
B. No, I do not take but right now am considering taking my medication as 
directed.  
 
C. No, I do not take but am planning to start taking my medication as directed.  
 
D. Yes, right now I consistently take my medication as directed. 
 
If the answer to question 1 is D, then: 
 
2. How long have you been taking your medication as directed? 
A. ≤3 months 
 
B. >3 months to 6 months 
 
C. > 6 months to 12 months 
 









Aim 1 Interview Guide 
Improving Blood Pressure in Colorado 
PI: P. Michael Ho, MD, Ph. D. 
COMIRB # 06-0950 
 
Qualitative – Interview Guide 
 “To help make this a better program, we would like to ask you questions about your 
experience with this study, is that ok with you?  To be sure we collect all of the 
information you share we would like to audio tape this conversation with you, is that ok?” 
 
Intervention Patients 
1. “Please describe your experience when you took your blood pressure readings at 
home, please include the number of times each day and week.” (If issues or further 
explanation is required– “please explain what you mean by that.”) 
 
2. “Please describe any difficulties or problems you had with taking your BP at home.” (If 
issues or further explanation is required– “please explain what you mean by that.”) 
 
3. “Please describe your experience when you used the IVR system, please include the 
number of times each week.” (If issues or further explanation is required – “please 
explain what you mean by that.”) 
 
4. “Please describe any difficulties or problems you had with using the IVR system.” (If 
issues or further explanation is required– “please explain what you mean by that.”) 
5. “Could you tell us about your experience when the IVR system called you?” (If issues 
or further explanation is required – “please explain what you mean by that.”) 
 
6. “Could you tell us about your experience when you used any of the extra options on 
the IVR system?” Please include which options you used. (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
7. “Please describe your experience when you take your medicines, please include the 
number of times each day.” (If issues or further explanation is required – “please explain 
what you mean by that.”) 
 
8. “What makes it difficult to take your medicine?” (If issues or further explanation is 
required – “please explain what you mean by that.”) 
 
9. “Under what circumstances do you stop taking your medicines?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
10. “What effects did working with the pharmacist have on your effort to care for your 
health?” (If issues or further explanation is required – “please explain what you mean by 
that.”) 
 
11. “What effects did working with the pharmacist have on your efforts to take your 




12. What effects did working with the pharmacist have on your efforts to control your 
BP?” (If issues or further explanation is required – “please explain what you mean by 
that.”) 
 
13. “Tell us how your participation in this study has affected your decisions to see your 
doctor or not see her/him?” (If issues or further explanation is required – “please explain 
what you mean by that.”) 
 
14. “What barriers have kept you from seeing your doctor?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
15. “How has the program helped you to reduce doctor visits?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
16. “How has it helped you during visits?” (If issues or further explanation is required – 
“please explain what you mean by that.”) 
 
Usual Care Patients 
1. “Please describe your experience when you take your medicines, please include the 
number of times each day.” (If issues or further explanation is required – “please explain 
what you mean by that.”) 
 
2. “What makes it difficult to take your medicine?” (If issues or further explanation is 
required – “please explain what you mean by that.”) 
 
3. “Under what circumstances do you stop taking your medicines?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
4. “Tell us how your participation in this study has affected your decisions to see your 
doctor or not see her/him?” (If issues or further explanation is required – “please explain 
what you mean by that.”) 
 
5. “What barriers have kept you from seeing your doctor?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
6. “How has the program helped you to reduce doctor visits?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
7. “How has it helped you during visits?” (If issues or further explanation is required – 





Aim 3 Interview Guides 
 
MEDICATION STUDY 
PI: P. Michael Ho, MD, PhD 
COMIRB # 09-0457 
Amended 10/30/10 
 
Qualitative Interview Guide for Medication Adherenc e Study 
“To help make this a better program, we would like to ask you questions about your 
experience with this study, is that ok with you?  To be sure we collect all of the 
information you share we would like to audio tape this conversation with you, is that ok?” 
 
General questions for both arms: 
1. “Please tell me what does it mean to you to have a heart condition?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
 
2. “Do you believe your health has changed over this past year?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
a. If yes, “please tell me how you think it has changed?” 
b. If no, “please tell me why you think it hasn’t changed?” 
 
3. “Please tell me what you think is the connection between your heart medicines 
and your heart condition?” (If issues or further explanation is required – “please explain 
what you mean by that.”) 
 
4. ”Do you believe that the medicines have any effect on your health?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
 
5. “Please tell me what you like and dislike about taking medicines?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
 
6. “Please tell me how do you feel when the doctor is talking to you about your 
medicines?” (If issues or further explanation is required – “please explain what you mean 
by that.”) 
a. “Do you feel you can tell him/her that you disagree?”  
b. “Do you feel you can tell him/her that you don’t like a particular medicine, 
or how many times you have to take it?” 
 
7. “What are some things that get in the way of you taking your medicine?” (If 
issues or further explanation is required – “please explain what you mean by that.”) 
 
8. “Do you have any suggestions for helping people to take prescribed 
medications?” (If issues or further explanation is required – “please explain what you 
mean by that.”) 
 
Intervention Arm: 
1. “Did participating in this study affect your understanding of medicines in 




2. What effects did working with the pharmacist have on you?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
3. “What effects did working with the pharmacist have on your efforts to take your 
meds? (If issues or further explanation is required – “please explain what you mean by 
that.”) 
 
4. “Tell me your thoughts about the IVR educational messages?” Please explain in 
full detail. (If issues or further explanation is required – “please explain what you mean 
by that.” 
 
5. “Tell me your thoughts about the IVR system medication refill reminder 
messages?” Please explain in full detail. (If issues or further explanation is required – 
“please explain what you mean by that.” 
 
6. “Do you believe the way the medical staff (doctor, nurse, pharmacist) interacts 
with you has an effect on your decision to take your medicine?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
Control patients: 
1. “Did participating in this study affect your understanding of medicines in 
general?” (If issues or further explanation is required – “please explain what you mean 
by that.”) 
 
2. “Do you believe the way the medical staff (doctor, nurse, pharmacist) interacts 
with you has an effect on your decision to take your medicine?” (If issues or further 






PI: P. Michael Ho, MD, PhD 
COMIRB # 09-0457 
Amended 8/5/11 
Qualitative Interview Guide for Medication Adherenc e Study 
 
“To help make this a better program, we would like to ask you questions about your 
experience with this study, is that ok with you?  To be sure we collect all of the 
information you share we would like to audio tape this conversation with you, is that ok?” 
 
General questions for both arms: 
1. “Please tell me what does it mean to you to have had a heart attack?” (If issues 
or further explanation is required – “please explain what you mean by that.”) 
 
2. “Do you believe your health status has changed over this past year?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
a. If yes, “please tell me how you think it has changed?” 
b. If no, “please tell me why you think it hasn’t changed? 
 
3. “Please tell me what do you believe having had a heart attack and medicines 
have to do with each other?” (If issues or further explanation is required – “please 
explain what you mean by that.”)  
 
4. “Do you believe that the medicines have any effect on your health status?” (If 
issues or further explanation is required – “please explain what you mean by 
that.”) 
 
5. “Please tell me what you like and dislike about taking medicines?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
 
6. “Please tell me how do you feel when the doctor is talking to about your 
medicines?” (If issues or further explanation is required – “please explain what 
you mean by that.”) 
a. “Do you feel you can tell him/her that you disagree?”  
b. “Do you feel you can tell him/her that you don’t like a particular medicine 
c. Or how many times you have to take it?” 
. 
7. “What are some things that get in the way of you taking your medicine?” (If 
issues or further explanation is required – “please explain what you mean by 
that.”) 
 
8. “Do you have any suggestions for helping people to take prescribed 
medications?” (If issues or further explanation is required – “please explain what 
you mean by that.”) 
 
Intervention Arm: 
1. “Did participating in this study affect your understanding of medicines in 
general?” (If issues or further explanation is required – “please explain what you 
mean by that.”)  
120 
 
2. What effects did working with the pharmacist have on you?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
3. “What effects did working with the pharmacist have on your efforts to take your 
meds? (If issues or further explanation is required – “please explain what you 
mean by that.”)  
 
4. “Tell me your thoughts about the IVR educational messages?” Please explain in 
full detail. (If issues or further explanation is required – “please explain what you 
mean by that.”  
a. What impact of the messages on your health behavior?  
b. What impact of the messages on your health status? 
 
5. “Tell me your thoughts about the IVR system medication refill reminder 
messages?” Please explain in full detail. (If issues or further explanation is 
required – “please explain what you mean by that.”  
a. What impact of the messages on your health behavior?  
b. What impact of the messages on your health status? 
 
6. “Do you believe the personality of the medical staff (doctor, nurse, pharmacist) 
has an effect on your decision to take your medicine?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
Control patients: 
1. “Did participating in this study affect your understanding of medicines in 
general?” (If issues or further explanation is required – “please explain what you 
mean by that.”) 
 
2. “Do you believe the personality of the medical staff (doctor, nurse, pharmacist) 
has an effect on your decision to take your medicine?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
3. What impact being in the study had your health behavior?  
 
4. What impact of being in the study have on your health status? 
 
Questions about costs for final study visits: 
1. Over the past year, how much, on average, did you pay out of pocket for your 
“heart” medications each month? 
 
2. Are there any “heart” medications you don’t refill because of the cost? 
 
3. Do you have insurance (other than VA) to help with medication costs?  
 






PI: P. Michael Ho, MD, PhD 
COMIRB # 09-0457 
Amended 3/23/12 
 
Qualitative Interview Guide for Medication Adherenc e Study 
 
“To help make this a better program, we would like to ask you questions about your 
experience with this study, is that ok with you?  To be sure we collect all of the 
information you share we would like to audio tape this conversation with you, is that ok?” 
 
General questions for both arms: 
1. “Please tell me about having had a heart attack/heart condition?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
 
2. “Do you believe your health has changed over this past year?” (If issues or 
further explanation is required – “please explain what you mean by that.”)  
a. If yes, “please tell me how you think it has changed?” 
b. If no, “please tell me why you think it hasn’t changed?” 
 
3. “Please tell me your thoughts and opinions about your medicines and how they 
relate to your heart? (If issues or further explanation is required – “please explain 
what you mean by that.”) 
 
4. “Please tell me about your relationship with your providers?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
a. “If you disagree with your provider how do you feel about sharing that with 
them?” (If issues or further explanation is required – “please explain what 
you mean by that.”) 
 
5. “What are some things that get in the way of you taking your medicine?” (If 
issues or further explanation is required – “please explain what you mean by 
that.”) 
 
6. “Do you have any suggestions for helping people to take prescribed 
medications?” (If issues or further explanation is required – “please explain what 
you mean by that.”) 
 
7. Please tell me what you believe are important factors in keeping you healthy? (If 




1. “Please tell me about your experience in this study?” 
 
2. “Did participating in this study affect your understanding of medicines in 
general?” (If issues or further explanation is required – “please explain what you 




3. What effects did working with the pharmacist have on you?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
a. “Were there any effects on your efforts to take your meds? (If issues or 
further explanation is required – “please explain what you mean by that.”)  
 
4. Did you receive any computerized messages from this study? 
 
5. If yes:“Tell me your thoughts about the IVR educational messages?” Please 
explain in full detail. (If issues or further explanation is required – “please explain 
what you mean by that.”  
a. What impact of the messages on your eating or exercising habits?  
 
6. If yes: “Tell me your thoughts about the IVR system medication refill reminder 
messages?” Please explain in full detail. (If issues or further explanation is 
required – “please explain what you mean by that.”  
a. What impact of the messages on taking your medicines? 
 
7. Please tell me your thoughts and opinions of using phone technology 
(Educational voice messages and reminders to pick up your medicines or other 
things you know about) in your medical care? 
 
Control patients: 
1. “Did participating in this study affect your understanding of medicines in 
general?” (If issues or further explanation is required – “please explain what you 
mean by that.”) 
 
2. Please tell me your thoughts and opinions of using phone technology 
(Educational voice messages and reminders to pick up your medicines or other 
things you know about) in your medical care? 
 
Questions about costs for final study visits: 
1. Over the past year, how much, on average, did you pay out of pocket for your 
“heart” medications each month? 
 
2. Are there any “heart” medications you don’t refill because of the cost? 
 
3. Do you have insurance (other than VA) to help with medication costs?  
 








PI: P. Michael Ho, MD, PhD 
COMIRB # 09-0457 
Amended 8/6/12 
 
Qualitative Interview Guide for Medication Adherenc e Study 
 
“To help make this a better program, we would like to ask you questions about your 
experience with this study, is that ok with you?  To be sure we collect all of the 
information you share we would like to audio tape this conversation with you, is that ok?” 
 
General questions for both arms: 
1. “Please tell me about having had a heart attack/heart condition?” (If issues or 
further explanation is required – “please explain what you mean by that.”) 
 
2. “Do you believe your health has changed over this past year?” (If issues or 
further explanation is required – “please explain what you mean by that.”)  
a. If yes, “please tell me how you think it has changed?” 
b. If no, “please tell me why you think it hasn’t changed?” 
 
3. “Please tell me your thoughts and opinions about your medicines and how they 
relate to your heart? (If issues or further explanation is required – “please explain 
what you mean by that.”) 
 
4. “Please tell me about your relationship with your providers?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
 
a. Do you comply with the directions your provider gives you?  For example 
people have told us that they do everything their providers say to do: they 
take all their meds and do all the things like exercise and eat right OR 
they don’t do any of the things the provider says to do.  Where do you fit? 
 
b. “If you disagree with your provider how do you feel about sharing that with 
them?” (If issues or further explanation is required – “please explain what 
you mean by that.”) 
i. So when you didn’t agree with them were you comfortable telling 
them you didn’t agree?   
ii. If you don’t agree again where do you fit in the spectrum of 
complying with their directions? 
 
5. “Do you have any suggestions for helping people to take prescribed 
medications?” (If issues or further explanation is required – “please explain what 
you mean by that.”) 
 
6. Please tell me what you believe are important factors in keeping you healthy? (If 








1. “Please tell me about your experience in this study?” 
 
2. “Did participating in this study affect your understanding of medicines in 
general?” (If issues or further explanation is required – “please explain what you 
mean by that.”) Be sure to go further if response is yes/no.  
 
3. What effects did working with the pharmacist have on you?” (If issues or further 
explanation is required – “please explain what you mean by that.”) 
a. “Were there any effects on your efforts to take your meds? (If issues or 
further explanation is required – “please explain what you mean by that.”)  
4. Did you receive any computerized messages from this study? 
 
5. If yes:“Tell me your thoughts about the IVR educational messages?” Please 
explain in full detail. (If issues or further explanation is required – “please explain 
what you mean by that.”  
a. What impact of the messages on your eating or exercising habits?  
 
6. If yes: “Tell me your thoughts about the IVR system medication refill reminder 
messages?” Please explain in full detail. (If issues or further explanation is 
required – “please explain what you mean by that.”  
a. What impact of the messages on taking your medicines? 
 
7. Please tell me your thoughts and opinions of using phone technology 
(Educational voice messages and reminders to pick up your medicines or other 
things you know about) in your medical care? 
 
Control patients: 
1. “Did participating in this study affect your understanding of medicines in 
general?” (If issues or further explanation is required – “please explain what you 
mean by that.”) 
 
2. Please tell me your thoughts and opinions of using phone technology 
(Educational voice messages and reminders to pick up your medicines or other 
things you know about) in your medical care? 
 
Questions about costs for final study visits: 
1. Over the past year, how much, on average, did you pay out of pocket for your 
“heart” medications each month? 
 
2. Are there any “heart” medications you don’t refill because of the cost? 
 
3. Do you have insurance (other than VA) to help with medication costs?  
 
4. Is there anything else about medication costs you would like us to know? 
 
 
